Apparatus and method for suturing body lumens

Information

  • Patent Grant
  • 11154293
  • Patent Number
    11,154,293
  • Date Filed
    Friday, October 10, 2014
    10 years ago
  • Date Issued
    Tuesday, October 26, 2021
    3 years ago
Abstract
A medical apparatus that includes a distal member, a needle disposed in the distal member and proximally advanceable from the distal member, and a needle capture portion positioned proximal to the distal member and which includes a through-hole to direct the needle from the needle capture portion towards a graspable member at a trajectory narrower than a trajectory of the needle from the distal member to the needle capture portion.
Description
BACKGROUND

1. Technical Field


The present disclosure relates generally to techniques and devices for closing openings in body lumens. More particularly, the present disclosure relates to systems, devices, and methods for percutaneous closure of arterial and venous puncture sites, which are usually accessed through a tissue tract.


2. The Relevant Technology


Many diagnostic and interventional vascular procedures are now performed translumenally. A catheter is introduced to the vascular system at a convenient access location and guided through the vascular system to a target location using established techniques. Such procedures require vascular access, which is usually established using the well-known Seldinger technique. Vascular access is generally provided through an introducer sheath, which is positioned to extend from outside the patient's body into the vascular lumen. When vascular access is no longer required, the introducer sheath is removed and bleeding at the puncture site is stopped using one of a variety of methods.


One method for providing hemostasis (the cessation of bleeding) is to apply external force near and upstream from the puncture site, typically by manual compression. This approach suffers from a number of disadvantages. For example, the manual compression procedure is time consuming, frequently requiring 30 or more minutes of compression before hemostasis is achieved. Additionally, such compression techniques rely on clot formation, which can be delayed until anticoagulants used in vascular therapy procedures (such as for heart attacks, stent deployment, non-optical PTCA results, and the like) wear off. The anticoagulants may take two to four hours to wear off, thereby increasing the time required before completion of the manual compression procedure.


Further, the manual compression procedure is uncomfortable for the patient and frequently requires analgesics to be tolerable. Moreover, the application of excessive pressure can at times totally occlude the underlying blood vessel, resulting in ischemia and/or thrombosis. Following manual compression, the patient typically remains recumbent from four to twelve hours or more under close observation to assure continued hemostasis. During this time, renewed bleeding may occur, resulting in blood loss through the tract, hematoma and/or pseudo-aneurysm formation, as well as arteriovenous fistula formation. These complications may require blood transfusions and/or surgical intervention.


The incidence of complications from the manual compression procedure increases when the size of the introducer sheath grows larger, and/or when the patient is anticoagulated. The compression technique for arterial closure can be risky, and is expensive and onerous to the patient. Although using highly trained individuals can reduce the risk of complications, dedicating such personnel to this task is both expensive and inefficient. Nonetheless, as the number and efficacy of translumenally performed diagnostic and interventional vascular procedures increases, the number of patients requiring effective hemostasis for a vascular puncture continues to increase.


To overcome the problems associated with manual compression, bioabsorbable sealing bodies have been used. Generally, a thrombogenic and bioabsorbable material, such as collagen, is placed at the superficial wall of the body lumen over the puncture site. While potentially effective, this approach suffers from a number of drawbacks. For example, bioabsorbable sealing bodies may lack a solid mechanical attachment of the sealing body to the tissue. Due to the lack of a solid mechanical attachment, the sealing body can wander within the tissue tract or move out of the puncture site, thus causing late bleeds. Conversely, if the sealing body wanders and intrudes too far into the body lumen, due to the lack of a solid mechanical attachment, intravascular clots and/or collagen pieces with thrombus attached can form and embolize downstream, causing vascular occlusion.


BRIEF SUMMARY

This Summary is provided to introduce a selection of concepts in a simplified form that are further described below in the Detailed Description. This Summary is not intended to identify key features or essential features of the claimed subject matter, nor is it intended to be used as an aid in determining the scope of the claimed subject matter. Embodiments described herein provide systems, methods, and devices for closing an opening in tissue. Embodiments can be configured to close an opening within a body lumen.


For instance, in one embodiment, an apparatus for suturing a body lumen includes a flexible elongated member that has a proximal end, a distal end, a central passage and multiple needle lumens extending from the proximal end toward the distal end. The flexible elongated member further includes an elongated subsection spanning from the end of the needle lumens in the elongated member to a barrel portion that includes corresponding needle lumens on the proximal end of the elongated member. The elongated subsection provides sufficient space between the needles and the barrel portion to allow transapical insertion of the elongated member into a body lumen. The apparatus further includes multiple different needles disposed within and advanceable from the needle lumens in the flexible elongated member across the elongated subsection to corresponding needle lumens in the barrel portion. The apparatus also includes a handle disposed at the proximal end of the elongated member. The handle is operable to retract the needles through the needle lumens of the elongated member across the elongated subsection toward the handle at the proximal end.


In another embodiment, a method is provided for suturing an opening in a body lumen. The method includes providing a body lumen suturing device, where the body lumen suturing device includes a flexible elongated member that has a proximal end, a distal end, a central passage and multiple needle lumens extending from the proximal end toward the distal end. The flexible elongated member includes an elongated subsection spanning from the end of the needle lumens in the elongated member to a barrel portion that includes corresponding needle lumens on the proximal end of the elongated member. The elongated subsection provides sufficient space between the needles and the barrel portion to allow transapical insertion of the elongated member. The body lumen suturing device further includes needles disposed within and advanceable from the needle lumens in the flexible elongated member across the elongated subsection to corresponding needle lumens in the barrel portion, as well as a handle disposed at the proximal end of the elongated member, where the handle is operable to retract the needles through the needle lumens of the elongated member across the elongated subsection toward the handle at the proximal end.


In yet another embodiment, a body lumen suturing device includes a flexible elongated member having a proximal end, a distal end, a central passage and multiple needle lumens extending from the proximal end toward the distal end. The flexible elongated member further includes an elongated subsection spanning from the end of the needle lumens in the elongated member to a barrel portion that includes corresponding needle lumens on the proximal end of the elongated member. The elongated subsection provides sufficient space between the needles and the barrel portion to allow transapical insertion of the elongated member. The elongated member also includes a crimp ring configured to hold pledgets in place at the proximal end of the needle lumens in the elongated member. The device also includes needles disposed within and advanceable from the needle lumens in the flexible elongated member across the elongated subsection to corresponding needle lumens in the barrel portion, as well as one or more pledgets stored at the proximal end of the needle lumens in the elongated member. The pledgets include holes through which the sutures may be pulled. The device also includes a handle disposed at the proximal end of the elongated member, where the handle is operable to retract the needles through the needle lumens of the elongated member across the elongated subsection toward the handle at the proximal end.


Additional features and advantages will be set forth in the description which follows, and in part will be obvious from the description, or may be learned by the practice of the teachings herein. Features and advantages of the invention may be realized and obtained by means of the instruments and combinations particularly pointed out in the appended claims. Features of the present invention will become more fully apparent from the following description and appended claims, or may be learned by the practice of the invention as set forth hereinafter.





BRIEF DESCRIPTION OF THE DRAWINGS

To further clarify the above and other advantages and features of embodiments of the present invention, a more particular description of embodiments of the present invention will be rendered by reference to the appended drawings. It is appreciated that these drawings depict only typical embodiments of the invention and are therefore not to be considered limiting of its scope. The invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:



FIG. 1 illustrates a side view of an example embodiment of the suturing device.



FIG. 2 illustrates insertion of the elongate member and barrel portion.



FIG. 3 is a perspective view of an example embodiment of a suturing device.



FIG. 4A is a detailed view of the distal end of the suturing device of the suturing device of FIG. 2, shown with the needles retracted fully within the suturing device.



FIG. 4B is a detailed view similar to FIG. 4A, except that the needles have been partially deployed into tissue to the sides of the suturing device.



FIG. 5. is a cross-sectional view of the device of FIGS. 4A and 4B, taken along line 5-5 of FIG. 4B.



FIGS. 6A-6J illustrate various embodiments of the suturing device that implement pledgets.



FIG. 7 illustrates a barrel comprising semi-circular openings on the distal end configured to draw the needles toward a narrow exit hole on the proximal end of the barrel.



FIG. 8 illustrates the X-pattern of the tied suture applied by the suturing device.





DETAILED DESCRIPTION

Embodiments described herein provide systems, methods, and devices for closing an opening in tissue. Embodiments can be configured to close an opening within a body lumen. For instance, in one embodiment, an apparatus for suturing a body lumen includes a flexible elongated member that has a proximal end, a distal end, a central passage and multiple needle lumens extending from the proximal end toward the distal end. The flexible elongated member further includes an elongated subsection spanning from the end of the needle lumens in the elongated member to a barrel portion that includes corresponding needle lumens on the proximal end of the elongated member. The elongated subsection provides sufficient space between the needles and the barrel portion to allow transapical insertion of the elongated member into a body lumen. The apparatus further includes multiple different needles disposed within and advanceable from the needle lumens in the flexible elongated member across the elongated subsection to corresponding needle lumens in the barrel portion. The apparatus also includes a handle disposed at the proximal end of the elongated member. The handle is operable to retract the needles through the needle lumens of the elongated member across the elongated subsection toward the handle at the proximal end.


In another embodiment, a method is provided for suturing an opening in a body lumen. The method includes providing a body lumen suturing device, where the body lumen suturing device includes a flexible elongated member that has a proximal end, a distal end, a central passage and multiple needle lumens extending from the proximal end toward the distal end. The flexible elongated member includes an elongated subsection spanning from the end of the needle lumens in the elongated member to a barrel portion that includes corresponding needle lumens on the proximal end of the elongated member. The elongated subsection provides sufficient space between the needles and the barrel portion to allow transapical insertion of the elongated member. The body lumen suturing device further includes needles disposed within and advanceable from the needle lumens in the flexible elongated member across the elongated subsection to corresponding needle lumens in the barrel portion, as well as a handle disposed at the proximal end of the elongated member, where the handle is operable to retract the needles through the needle lumens of the elongated member across the elongated subsection toward the handle at the proximal end.


In yet another embodiment, a body lumen suturing device includes a flexible elongated member having a proximal end, a distal end, a central passage and multiple needle lumens extending from the proximal end toward the distal end. The flexible elongated member further includes an elongated subsection spanning from the end of the needle lumens in the elongated member to a barrel portion that includes corresponding needle lumens on the proximal end of the elongated member. The elongated subsection provides sufficient space between the needles and the barrel portion to allow transapical insertion of the elongated member. The elongated member also includes a crimp ring configured to hold pledgets in place at the proximal end of the needle lumens in the elongated member. The device also includes needles disposed within and advanceable from the needle lumens in the flexible elongated member across the elongated subsection to corresponding needle lumens in the barrel portion, as well as one or more pledgets stored at the proximal end of the needle lumens in the elongated member. The pledgets include holes through which the sutures may be pulled. The device also includes a handle disposed at the proximal end of the elongated member, where the handle is operable to retract the needles through the needle lumens of the elongated member across the elongated subsection toward the handle at the proximal end.


As used herein, the term “distal” is generally defined as in the direction of the patient, or away from a user of a device, or in a downstream direction relative to a forward flow of blood. In the context of a medical device intervention with or through a vessel wall, “distal” herein refers to the interior or the lumen side of the vessel wall.


Conversely, “proximal” generally means away from the patient, or toward the user, or in an upstream direction relative to a forward flow of blood. In the context of a medical device intervention with or through a vessel wall, “proximal” herein refers to the exterior or outer side of the vessel wall.


Additionally, “oblong” is herein intended to mean oval, elliptical, or otherwise having a generally rounded shape that is not perfectly circular. In particular, the term describes the shape of a tubular graft end cut at an acute angle relative to the plane perpendicular to the tissue walls defining the graft.


The term “hemostasis” is herein used to mean the arrest of bleeding or substantially blocking flow of blood outwardly from a vessel lumen while the vessel lumen is pressurized or sustaining physiological blood flow. This amount of blockage or occlusion to flow is further defined such that the blood loss which is experienced is less than an amount which would affect procedural methods or outcomes according to a physician user of a device of ordinary skill in the art. In other words, “hemostasis” is not intended to mean only “total hemostasis” such that there is a total lack of blood loss. Rather, the term is used to also mean “procedural hemostasis” as a relative term in its use among physicians of ordinary skill.


Similarly, “occlusion,” “occlude,” “blockage,” “block . . . plugging”, “block,” or variations thereof are all terms which are herein intended to have a procedurally relevant definition in the context of their use. For instance, an aperture is “occluded” although there is some measurable flow therethrough, but that flow is so low such that the intended procedural benefit of occlusion is at least partially achieved. Certainly, such terms also properly include within their scope a “total effect” definition, as well.


The term “perfusion” is herein used to mean the flow of blood or other unit of perfusate (the fluid used for perfusion) per unit volume of tissue. Physiological perfusion refers to the amount of blood flow present when the body is functioning normally. For example, physiological perfusion usually prevents clinically significant ST elevations which is one of the most sensitive indicators of inadequate perfusion. Adequate perfusion refers to the amount of blood flow that avoids the clinical requirement of transfusing the patient or that is needed to prevent tissue necrosis distal to the aperture in the blood vessel.


The term “suturing” is herein intended to include the process of joining two surfaces or edges together with a fastener so as to close an aperture, opening, or wound or join tissues. The fastener is usually a suture such as a thread of material (either polymeric or natural), gut, wire or the like. The term fastener as used herein also includes clamps, studs, hasps, catches, hooks, rivets, staples, snaps, stitches, VELCRO, buttons, and other coupling members.


As shown in FIG. 1, a tissue suturing device 101 may be provided to close openings in body tissues. The tissue suturing device 101 includes multiple different parts. These parts may be generally divided into three sections including a handle section 192, a substantially rigid intermediate section 191, and a flexible elongated section 190. Each section may include different sub-parts that are each designed to provide an intended portion of functionality.


The handle section 192 of the tissue suturing device 101 includes a hand grip 110 and rotatable handle portion 109R. The hand grip and rotatable handle portion allow a physician or other user to hold and manipulate the tissue suturing device 101. For example, the physician can hold on to the hand grip 110 and the rotatable handle portion 109R when inserting or withdrawing the tissue suturing device from a body lumen. The handle section 192 also includes an actuating member (i.e. handle 109N) which is mechanically linked to the needles 115 (FIG. 4A) in the elongated member 113. When the handle 109N is pulled, the mechanical link to the needles is actuated and the needles are drawn from the distal end 113D of the elongated member toward the proximal end 113P of the elongated member. As will be shown further in regard to FIGS. 2 and 3, the handle 109N is mechanically linked to a needle holder 121 which holds the needles within the sheath 105. When the handle 109N is pulled toward the user, the needle holder moves, along with the needles, through the sheath 105 and toward the handle.


The substantially rigid intermediate section 191 extends from the rotatable handle portion 109R to the needle guide 106. This intermediate section includes a barrel portion 108 which routes the needles 115 through the barrel and out toward the handle portion 192. The needles 115 carry sutures 112 which are used to close openings in the tissue. The needles extend from the needle guide 106 through any intervening tissue toward the barrel portion 108. The barrel portion 108 captures the needles and routes them through an opening (element 124 in FIG. 2) toward the user. The substantially rigid intermediate section 191 also includes elongated subsection 107 which spans a tissue gap. This tissue gap comprises the tissue area through which the elongated subsection is inserted. The elongated subsection allows for the tissue suturing device 101 to be inserted transapically into the heart or into other bodily tissues. In some embodiments, the elongated subsection 107 may allow a user to insert the device transapically and perform a percutaneous closure of the left ventricle of the heart. This embodiment will be explained in greater detail below.


The flexible elongated portion 190 of the tissue suturing device 101 includes the needles 115 (shown in FIGS. 2-4), a guidewire port for advancing the device along a guidewire 114 (shown in FIG. 2) and a flexible outer sheath 105. The flexible elongated portion 190 may be inserted entirely into the body lumen using the guidewire to advance the device. Once the tissue suturing device has been inserted into the vascular tissue, the guidewire can be removed by the operator. The sheath 105 of the elongated member 113 supports various internal structures including the needle holder 121. The flexibility of the elongated portion allows the elongated portion to be inserted in a variety of different types and sizes of tissues, including into arteries (such as the femoral artery) and into the heart.


The needle holder 121 of the flexible elongated portion 190 may be configured to hold one or more needles within needle lumens 119 which are axially aligned and spaced about the interior of the elongated member 113 (as shown in the cross-sectional view of FIG. 5 (which itself corresponds to cross-section 5 of FIG. 3)). The needle holder, upon actuation of the handle 109, may be advanced up the needle shaft 111 toward the proximal end 113P of the elongated member 113. As the needle holder 102 is advanced, the needles 115 held by the needle holder are correspondingly advanced toward the needle shaft 111 in the handle 109. The needles are withdrawn through the needle guide 106 toward the barrel portion 108. As will be explained in greater detail with regard to FIG. 7, the barrel portion 108 includes two semi-circular openings 130 that receive the needles 115, even in cases where the needles are drawn through relatively large tissue gaps.


Thus, the flexible elongated portion 190 houses the needles 115 which will be drawn toward the handle 109 of the tissue suturing device 101. The needles 115 are withdrawn along needle guide 106 and across the tissue gap covered by elongated subsection 107 toward the barrel portion 108. While being advanced from the needle guide 106 to the barrel portion 108, the needles may exhibit a tendency to deflect or travel away from the tissue suturing device 101. For example, in cases where the tissue suturing device 101 is inserted transapically into the left ventricle of the heart, the tissue suturing device will be inserted through body tissue that is thicker and/or tougher than the body tissue typically involved in a femoral arteriotomy. For instance, the tissue gap in a transapical insertion may be 1-5 cm. In a femoral arteriotomy, a tissue suturing device is placed through skin and muscle tissue in the leg, and ultimately through the femoral artery. In a transapical insertion, the tissue suturing device is inserted near or through the ribcage toward the heart. This tissue near the ribcage and heart is often fibrous and tough, and may cause the needles to deflect and travel away from the tissue suturing device. Accordingly, larger, semi-circular openings 130 are provided in the barrel portion 108 to capture the needles 115 as they approach the handle 109.


Thus, to compensate for the thicker, more fibrous tissue through which the tissue suturing device 101 will be inserted, a tissue suturing device with a substantially rigid elongated subsection 107 is provided. The elongated subsection 107 provides sufficient space between the needle guides 106 and the needle-receiving barrel portion 108 to allow transapical insertion of the device 101. The needles 115 are drawn through the tissue and across the tissue gap provided by the elongated subsection 107. The elongated subsection 107 is specifically designed to provide sufficient space between the needles 115 and the barrel portion 108 to allow transapical insertion of the elongated member 113. This is shown in greater detail in FIGS. 2-4. It should be noted that although the tissue suturing device is usable for transapical insertion into a heart ventricle, it will be appreciated that the tissue suturing device 101 can be readily adapted for use with punctures made to other hollow body organs and lumens. It may, however, be necessary to modify the dimensions and other particular aspects of the tissue suturing device to accommodate the different usage environments.


Referring now to FIGS. 2 and 3, the tissue suturing device 101 is suitable for suturing and sealing of a percutaneous vascular puncture site (particularly those made transapically to the left ventricle of the heart). The tissue suturing device 101 has an elongated member 113 and the needle shaft 111. The elongated member 113 includes a guide tip 123 of the needle guide 106 at its distal end. The guide tip 123 includes a plurality of guide channels 125 which receive the proximal ends of needles 115. The needles 115, as illustrated, comprise a sharpened tip section 115A and an elongated shank portion 122, but may also be manufactured as an integral piece. The shank portion 122 may be sufficiently long so that the needles may be pushed from their butt end by a needle holder 121 fixedly attached to the needle shaft 111. By withdrawing the handle 109N, the mechanically linked needle holder 121 is also withdrawn toward the user, carrying the needles 115 and pushing the needles through the intervening tissue. The needles may be withdrawn until they enter the barrel portion 108 and exit through the barrel opening 124.


The elongated member 113 further includes a plurality of needle lumens 119 which are axially aligned and spaced about the periphery of the elongated member. As shown in FIGS. 4B and 5, the needles 115 are designed to enter the proximal ends of the lumens 119 as the needles are advanced proximally relative to the elongated member 113. A flexible needle sheath (channel guide) 105 is attached to the guide tip 123 of the elongated member 113. The central lumen of the needle sheath 105 receives a needle holder 121 attached to the distal end of the needle shaft 111, as well as the needles 115. The butts of the needles 115 are removably received within the needle holder 121. The sheath 105 is designed to be sufficiently long to permit the needles to extend at least 5 cm beyond the distal end of elongated member 113 and into the barrel portion 108.


Prior to use, the tissue suture device 101 will be in the configuration illustrated in FIGS. 1 and 4A. That is, the needle shaft 111 will be distally positioned within the elongated member 113 and needle sheath 105. In particular, the tips of needles 115A will lie just at the guide tip 123 so that they may be easily advanced through the vascular tissue of the heart, as well as any surrounding tissue. That is, the tips of the needles 115A will be generally retracted within the guide tip 123. A length of suture 112 is attached to the proximal tips 115A of opposed pairs of needles 115, with the connecting suture being stored within side lumens 126 extending axially along the exterior of the needle sheath 105.


As best observed in FIGS. 4A, 4B and 5, the suture 112 extending between one pair of opposed needles is received in a first of the side lumens 126, while the suture extending between the other pair of opposed needles is received in the second of the side lumens 126. In some embodiments, the sutures 112 may be stored in the lumens 119 of the elongated member 113 (and thus eliminate the need for side lumens 126). The use of side lumens 126 may simplify feeding of the suture as the needles 115 are withdrawn.


After the guide tip 123 has been passed through the puncture site to be sutured, the needles may then be drawn proximally forward through the tissue to be sutured by drawing proximally on handle 109 at the proximal end of needle shaft 111. Methods described herein for suturing an opening in a body lumen will now be described in more detail with reference to FIGS. 2-4.


The situation following an interventional or other vascular procedure, where the attending physician is satisfied that the puncture site may be sealed, is illustrated in FIG. 2. The device 101 may then be introduced over a guidewire 114, as illustrated in FIG. 2. The needles 115 and sutures 112 mostly encased by flexible needle sheath 105, will be fully advanced into the artery or ventricle FA past the puncture site A. The handle 109N may then be partially withdrawn proximally to expose the needle lumens 119 (as shown in FIGS. 1, 4A and 4B).


The handle 109N will then be drawn proximally outward relative to the elongated member 113, causing the needles 115 to pass out of the needle lumens 119 and through the superficial wall of the artery/ventricle FA, as illustrated in FIGS. 2 and 4B. The handle 109 may continue to be drawn proximally (i.e., outward from the patient) in order to continue to pull the needle shaft 111 through the elongated member 113. Such movement of the needle shaft 111, in turn, continues to draw the needles 115 outward through the lumens 119 of the elongated member 113 until the tips of the needles are exposed.


As mentioned above, the needles 115 are drawn from out of needle lumens 119 and through any intervening tissue. The tissue may be thick and fibrous, as is the case when the tissue suturing device is inserted transapically into the heart. The device's elongated subsection 107 provides sufficient rigidity and stiffness for insertion through and placement in the thick and fibrous tissue. It is across this elongated subsection 107 and through this tissue that the needles 115 are withdrawn. In some cases, the needles 115 may deflect or drift while traveling through this tissue. Upon reaching the outer surface of the tissue, the needles may be guided into the semicircular openings of the barrel portion 108. The needles will thus carry their attached sutures 112 through the tissue, across the elongated subsection 107, and through the barrel portion 108. The sutures can then be grasped by the user and drawn out until the sutures are available to the user. The elongated member 113 may then be withdrawn from the needle sheath 105, leaving a portion of the needle sheath 105 still in the puncture site A to maintain hemostasis. The suture can then be tied and the knot pushed back down to the puncture site A. The knot will then only be tightened when the needle sheath is finally withdrawn from the puncture site A.


It can be seen that the guide tip 123 deflects the needles radially outward so that the pattern of four needles engages the arterial or ventrical wall in an approximately square pattern. These needles are then captured by the barrel portion 108. As shown in FIG. 7, the barrel portion captures the needles 115 traveling toward the handle 109. The needles 115 enter the distal end of the barrel portion 108 through one of two semi-circular openings 130 (in some cases, there may be more or fewer openings, and the openings may be in shapes other than semi-circles). The outer surface at the proximal end of the barrel portion 108 includes a hole 124 connected to the semi-circular openings 130 through which the needles 115 are withdrawn. As such, the openings 130 direct the needles on a narrower trajectory toward the handle 109 of the suturing apparatus. The needles are drawn across the elongated subsection 107 in order to reach the barrel portion 108. The elongated subsection 107 may be a predefined length, and may be specifically designed for the tissue though which the elongated member 113 is to be inserted.


For instance, as mentioned above, when the suturing device 101 is transapically inserted into the left ventricle of the heart, the elongated subsection 107 may comprise a specific length (e.g. within the range of 1-5 cm) for that type and/or thickness of tissue. Other types of insertion may necessitate use of a longer or shorter elongated subsection 107. In some cases, the diameter of the barrel portion 108 may be proportional to the thickness of the tissue (i.e. the tissue gap). Thus, in cases where the tissue gap is longer (e.g. within the range of 4-5 cm) and the needles are more prone to drift, the barrel portion 108 may be larger. Conversely, in cases where the tissue gap is shorter (e.g. within the range of 1-2 cm) and the needles are less prone to drift, the barrel portion 108 may be smaller in diameter.


In specific cases where the body lumen suturing device is inserted into the left ventricle of the heart transapically, and implemented to suture an opening in the left ventricle of the heart, the elongated member 113 of the tissue suturing device 101 may be advanced through the body lumen opening so that the needle lumens 119 are entirely within the body lumen 150. The elongated member 113 of tissue suturing device 101 may be advanced in this manner until it is substantially aligned with the interior wall of the body lumen. One or more pledgets 116 stored at the proximal end of the needle lumens 119 in the elongated member 113 may be placed between the needle ends and the interior wall of the body lumen (as shown in FIG. 6C). The needles 115A/115B and attached sutures 114A/114B are withdrawn through holes 118 in the pledget(s) 116. As such, the pledgets remain in contact with the interior wall of the body lumen 150, protecting the interior wall from forces applied to the sutures. The handle 109 may then be actuated to withdraw the needles 115 carrying the sutures 112 along the needle lumens 119, through the interior wall of the body lumen 150, and out through the opening 124 of the barrel portion 108. After the sutures are tied and the knots advanced back through the needle sheath 105, the resulting pattern of tied suture will appear as in FIG. 8 when viewed towards adventitial surface of the body.


Turning now to another embodiment, the tissue suturing apparatus 101 may further be designed to implement pledgets. As used herein, a pledget may refer to an absorbent pad or other cloth- or cotton-like material for absorbing bodily fluids. In some cases, the pledgets may be fabricated using biocompatible and/or absorbable materials, and may be used accordingly in different applications. For instance, pledgets may be placed interior to or exterior to a body lumen. Accordingly, a pledget may be placed inside an arterial wall, outside an arterial wall, or elsewhere in the body. In embodiments where pledgets are used in ventricles of the heart, the pledgets may protect the inner ventricle from cutting of the tissue by knot advancement, tying or by other causes. The pledgets may be stored at the end of the proximal end of the needle lumens 119. The sutures 114A/114B may be routed through holes the pledgets. These holes are large enough not to restrict suture travel. The pledgets may be held in place by crimp ring 134. These concepts will be explained below with regard to FIGS. 6A-6D.



FIG. 6A illustrates a zoomed-in view of the proximal end of the needle lumens 119, and the distal end of the elongated subsection 107. Needles 115A and 115B are shown still within the sheath 105 of the elongated member 113. Corresponding sutures 114A and 114B are attached to needles 115A and 115B. In some cases, the sutures may be of differing colors. For instance, suture 114A may be colored green, while suture 114B is colored white. The sutures may be drawn through a hole 118 in pledget 116. The pledget may be held in place by crimp ring 134 which extends around the elongated member 113.


As mentioned previously, the pledgets may be used both interior to and exterior to a vascular or arterial wall. Accordingly, FIG. 6B illustrates an embodiment where the pledget 116 is placed on the interior side of a body lumen (e.g. tissue 150). The sutures are threaded through the hole 118 in the pledget, and then through the tissue 150 as they are drawn toward the barrel portion 108 of the suturing apparatus. In this position, the pledget can alleviate bleeding in the vascular wall, and help to maintain hemostasis. Although shown with four needles 115 and two sutures, it should be noted that substantially any number of needles and/or sutures may be used in different scenarios. In some cases, it may be beneficial to have more or fewer needles and/or sutures. Accordingly, the suturing apparatus may be adapted (or remanufactured) to be used in these cases.


Thus, as shown in FIG. 6C, the sutures 114A/114B held by the needles 115 are threaded through the pledget 116, which is located between the sutures and the interior wall of the body lumen 150. In some cases, as shown in FIG. 6D, a second, different pledget may be placed in addition to (or as an alternative to) the pledget placed on the interior side of the body lumen (pledget 116B). Pledget 116A may be placed on the outside of the body lumen, and may function to alleviate bleeding on the outer part of the vascular wall. The exterior pledget (116A) may, like the interior pledget 116B, be threaded with sutures 114A and 114B. These sutures may be drawn through the pledget(s) and out through the puncture site (PS). Thus, in FIG. 6D, the sutures 114A/114B held by the needles 115 are threaded through the interior pledget 116B within the body lumen. The sutures 114A/114B are also threaded through the exterior pledget 116A which is exterior to the body lumen 150, such that the exterior pledget 116A is located between the exterior wall of the body lumen and the barrel portion 108 of the device 101. The pledgets 116A are stored at the proximal end 113P of the elongated member 113, and are held in place by a another crimp ring similar to crimp ring 134 and are configured to hold the pledgets in place at the proximal end of the elongated member until they are withdrawn along with the sutures and the needles toward the barrel portion 108.



FIGS. 6E and 6F show bottom and top views, respectively, of a pledget 116 with slits in various locations. The slits 180 may be placed on the outer edge of the pledget in order to allow a suture to be slid into place (as opposed to being threaded through a hole in the pledget). In FIG. 6E, the pledget has two slits on opposite sides. Each slit 180 is shown as having two sutures through it. While two sutures are used in the Figures, it will be appreciated that substantially any number of sutures and/or slits may be used. The bottom view of FIG. 6F illustrates that the sutures are slid through the slits and wrapped underneath the pledget. The ends of the sutures 112A and 112B come out of the top surface of the pledget, as illustrated in the top view of FIG. 6E. The pledget slits may be sewn or otherwise fastened shut, resulting in sewn edges 181. The edges may be sewn after the sutures have been slid into place. The slits thus allow the sutures to be slid into place on the pledget, while the sewn edges prevent the sutures from coming out of place.


These slits and sewn edges may be configured in different arrangements, as shown in FIGS. 6G-6J. FIG. 6H illustrates a bottom view of a pledget 116 that has crossing sutures 112A and 112B. The sutures may be slid into place using the respective slits 180. As can be seen on the corresponding top view (FIG. 6G), the sutures may extend out of the slits toward the user and/or toward the tissue suturing device. The sutures are held in place within the slits with the sewn edges 181. As with the pledgets described above, the pledgets of FIGS. 6E-6J can be held in place in the tissue suturing device 101 using crimp ring 134. Or, alternatively, the pledgets can be held in place by the sutures themselves. For example, if the sutures are crossed behind the suture as shown in FIG. 6H, the pledget may be drawn up next to the tissue suturing device with the sutures holding the pledget in place. Another pattern for placing sutures in a pledget is shown in FIGS. 6I and 6J. The sutures may be slid into place through slits 180, and may be aligned next to each other vertically (see bottom view FIG. 6J). The top ends of the sutures 112A and 112B are then available for the user or device as shown in the top view of FIG. 6I.


Accordingly, methods, systems and apparatuses are provided for suturing body lumens. A predefined tissue gap may be implemented to provide mechanisms for inserting the suturing device transapically into the left ventricle of the heart. Moreover, pledgets may be positioned within the suturing device for implementation on the exterior and interior walls of the body lumen. The placement of these pledgets may reduce blood loss and may assist in maintaining hemostasis.


The present invention may be embodied in other specific forms without departing from its spirit or essential characteristics. The described embodiments are to be considered in all respects only as illustrative and not restrictive. The scope of the invention is, therefore, indicated by the appended claims rather than by the foregoing description. All changes which come within the meaning and range of equivalency of the claims are to be embraced within their scope.

Claims
  • 1. A medical apparatus comprising: a distal member;a plurality of needles disposed in the distal member in a delivery pre-deployed state, the plurality of needles being proximally advanceable from the distal member to a deployed state;a needle support that supports distal ends of the plurality of needles and proximally pushes the distal ends to advance the needle tips of the plurality of needles from the distal member and through tissue, the plurality of needles being removably received within the needle support;a needle guide disposed proximal the needle support, the needle guide comprises a plurality of guide channels that direct the plurality of needles outwardly to penetrate the tissue; anda needle capture portion proximal the distal member and the needle guide, the needle capture portion comprising a distally facing first needle receiving opening and a second needle receiving opening proximal the first needle receiving opening, a state of the first needle receiving opening and the second needle receiving opening being the same with the plurality of needles in the pre-deployed state and the deployed state, the first needle receiving opening being configured to receive a plurality of the plurality of needles, the first needle receiving opening extending circumferentially about a longitudinal axis of the needle capture portion, the needle capture portion being configured to direct the plurality of needles at a trajectory different from a trajectory of the plurality of needles from the distal member to the needle capture portion.
  • 2. The medical apparatus of claim 1, further comprising an extension member disposed between the distal member and the needle capture portion, the extension member having a length specific to a target opening depth.
  • 3. The medical apparatus of claim 2, wherein the plurality of needles are disposed outside of an interior surface of the extension member at a distal end of the extension member adjacent the distal member.
  • 4. The medical apparatus of claim 2, wherein the plurality of needles are disposed outside of an interior surface of the extension member at a location intermediate a distal end and a proximal end of the extension member.
  • 5. The medical apparatus of claim 1, wherein the first needle receiving opening has an arced formation.
  • 6. The medical apparatus of claim 1, further comprising a pledget supported by the distal member and configured to receive the plurality of needles.
  • 7. The medical apparatus of claim 6, wherein each needle of the plurality of needles carries a suture and the pledget is configured to receive the plurality of needles and the suture.
  • 8. The medical apparatus of claim 1, wherein the plurality of needles are substantially equidistantly spaced about a longitudinal axis of the needle capture portion.
  • 9. The medical apparatus of claim 1, wherein a distal end of the needle capture portion has a first area, having an area substantially corresponding to an area of the first needle receiving opening.
  • 10. A medical apparatus comprising: a handle;a distal member;a plurality of needles disposed in the distal member with a needle tip of each needle facing proximally in a pre-deployed state, the plurality of needles being proximally advanceable from the distal member in a deployed state, the needle carrying a suture;a needle support that supports distal ends of the plurality of needles and proximally pushes the distal ends to advance the needle tips of the plurality of needles from the distal member and through tissue;a needle guide disposed proximal the needle support, the needle guide comprises a plurality of guide channels that direct the plurality of needles outwardly to penetrate the tissue; anda needle capture portion proximal the distal member and the needle guide, the needle capture portion comprising a distally facing first needle receiving opening and a second needle receiving opening disposed proximal the first needle receiving opening and distal the handle, a state of the first needle receiving opening and the second needle receiving opening being the same with the plurality of needles in the pre-deployed state and the deployed state the first needle receiving opening being disposed between an outer surface of the needle capture portion and a member extending from the needle capture portion, the needle capture portion being configured to direct the plurality of needles outwardly in relation to a longitudinal axis of the needle capture portion at a trajectory different from a trajectory of the plurality of needles from the distal member to the needle capture portion.
  • 11. The medical apparatus of claim 10, wherein a crimp ring supports a pledget disposed in the distal member and in a path of the plurality of needles exiting from the distal member.
  • 12. The medical apparatus of claim 10, wherein an extension member extends from a proximal end of the needle guide disposed within the distal member to a distal end of the needle capture portion, the trajectory of the plurality of needles from the distal member to the needle capture portion locates each needle of the plurality of needles adjacent an outer surface of the extension member.
  • 13. The medical apparatus of claim 10, further comprising a pledget disposed in the distal member and in a path of the plurality of needles exiting from the distal member, wherein the pledget includes at least one slit to receive the suture.
  • 14. A method for suturing a transapically accessed opening, the method comprising: positioning a medical apparatus adjacent the opening, the medical apparatus comprising: a handle;a distal member;a plurality of needles and a plurality of sutures, a needle tip of each of the plurality of needles facing proximally in a pre-deployed state, the plurality of needles being proximally advanceable from the distal member in a deployed state;a needle support that supports distal ends of the plurality of needles and proximally pushes the distal ends to advance the needle tips of the plurality of needles from the distal member and through tissue;a needle guide disposed proximal the needle support, the needle guide comprises a plurality of guide channels that direct the plurality of needles outwardly to penetrate the tissue; anda needle capture portion proximal the distal member and the needle guide, the needle capture portion comprising a distally facing first needle receiving opening and a second needle receiving opening disposed proximal the first needle receiving opening and distal the handle, a state of the first needle receiving opening and the second needle receiving opening being the same with the plurality of needles in the pre-deployed state and the deployed state the first needle receiving opening being disposed between an outer surface of the needle capture portion and a member extending from the needle capture portion, the needle capture portion being configured to direct the plurality of needles outwardly in relation to a longitudinal axis of the needle capture portion at a trajectory different from a trajectory of the plurality of needles from the distal member to the needle capture portion, wherein when viewed in a distal to proximal direction, and over at least a portion of a central angle of the first needle receiving opening, an outer perimeter of the first needle receiving opening approximates a curvature of the outer surface of the needle capture portion;advancing the distal member through the opening to dispose the distal member on an opposite side of the opening from the needle capture portion; andwithdrawing the plurality of needles carrying the plurality of sutures through tissue surrounding the opening and from the distal member into the needle capture portion.
  • 15. The method of claim 14, wherein the medical apparatus is inserted into the left ventricle of the heart transapically.
  • 16. The method of claim 14, wherein one or more pledgets are stored at a proximal end of the distal member and are placed between an end of the plurality of needles and tissue adjacent the opening.
  • 17. The method of claim 16, wherein withdrawing the plurality of needles carrying the plurality of suture comprises withdrawing the plurality of needles and the plurality of suture through holes in the pledgets, such that the one or more pledgets with the one or more pledgets remaining in contact with the tissue adjacent the opening to protect the tissue from forces applied to the plurality of sutures.
  • 18. The method of claim 14, further comprising directing the plurality of needles from a proximal end of the distal member through a plurality of needle guide channels, each of the needle guide channels directing the needle at the trajectory broader than the trajectory of the plurality of needles by the needle capture portion.
  • 19. The method of claim 14, further comprising grasping the plurality of needles with a grasping member to draw the plurality of needles proximally relative to the needle capture portion.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of application Ser. No. 13/455,053, entitled “Apparatus and Method for Suturing Body Lumens”, which was filed on Apr. 24, 2012, which is a continuation-in-part of application Ser. No. 13/443,659, entitled “Apparatus and Method for Suturing Body Lumens”, which was filed on Apr. 10, 2012, and which are incorporated by reference herein in their entireties.

US Referenced Citations (653)
Number Name Date Kind
312408 Wackerhagen Feb 1885 A
597165 Hall Jan 1898 A
659422 Shidler Oct 1900 A
989231 Davis Apr 1911 A
989234 Davis Apr 1911 A
1574362 Callahan Sep 1922 A
1625602 Gould et al. Apr 1927 A
1940351 Howard Mar 1933 A
2012776 Roeder Aug 1935 A
2131321 Hart Oct 1937 A
2108206 Mecker Feb 1938 A
2127903 Bowen Aug 1938 A
2371978 Perham Mar 1945 A
2397823 Walter Apr 1946 A
RE22857 Ogburn Mar 1947 E
2595086 Larzelere Nov 1948 A
2588589 Tauber Mar 1952 A
2610631 Calicchio Sep 1952 A
2646045 Priestley Jul 1953 A
2692599 Creelman Oct 1954 A
2941489 Fischbein Jun 1960 A
2959172 Held Nov 1960 A
3033156 Verlish May 1962 A
3104666 Hale et al. Sep 1963 A
3197102 Bates et al. Jul 1965 A
3359983 Northey Dec 1967 A
3413397 Bierbaum et al. Nov 1968 A
3422181 Chirgwin, Jr. Jan 1969 A
3470875 Johnson Oct 1969 A
3485234 Stevens Dec 1969 A
3587115 Shiley Jun 1971 A
3630205 Listner Dec 1971 A
3653388 Tenckhoff Apr 1972 A
3665926 Flores May 1972 A
3776237 Hill et al. Dec 1973 A
3802438 Wolvek Apr 1974 A
3814104 Irnich et al. Jun 1974 A
3820544 Semm Jun 1974 A
3840017 Violante Oct 1974 A
3874388 King et al. Apr 1975 A
3878848 Hiebert Apr 1975 A
3908662 Razgulov et al. Sep 1975 A
3918455 Coplan Nov 1975 A
3926194 Greenberg et al. Dec 1975 A
3939820 Grayzel Feb 1976 A
3985138 Jarvik Oct 1976 A
4011872 Komiya Mar 1977 A
4018228 Goosen Apr 1977 A
4069825 Akiyama Jan 1978 A
4109658 Hughes Aug 1978 A
4128100 Wendorff Dec 1978 A
4135623 Thyen Jan 1979 A
4161951 Scanlan, Jr. Jul 1979 A
4168073 LaRue Sep 1979 A
4182339 Hardy, Jr. Jan 1980 A
4185636 Gabbay et al. Jan 1980 A
4216776 Downie et al. Aug 1980 A
4217665 Bex et al. Aug 1980 A
4235177 Arbuckle Nov 1980 A
4235238 Ogiu et al. Nov 1980 A
4316469 Kapitanov Feb 1982 A
4317445 Robinson Mar 1982 A
4411654 Boarini et al. Oct 1983 A
4412832 Kling et al. Nov 1983 A
4437465 Nomoto et al. Mar 1984 A
4469101 Coleman et al. Sep 1984 A
4492229 Grunwald Jan 1985 A
4493323 Albright et al. Jan 1985 A
4501276 Lombardi Feb 1985 A
4553543 Amarasinghe Nov 1985 A
4554543 Wyatt et al. Nov 1985 A
4580566 Hsu Apr 1986 A
4586614 Ger May 1986 A
4587969 Gillis May 1986 A
4596559 Fleishhacker Jun 1986 A
4610248 Rosenberg Sep 1986 A
4629450 Suzuki et al. Dec 1986 A
4651733 Mobin-Uddin Mar 1987 A
4655211 Sakamoto et al. Apr 1987 A
4702250 Orvil et al. Oct 1987 A
4723549 Wholey et al. Feb 1988 A
4738666 Fuqua Apr 1988 A
4744364 Kensey May 1988 A
4748982 Horzewski et al. Jun 1988 A
4782954 Reynolds Nov 1988 A
4803984 Narayanan et al. Feb 1989 A
4823794 Pierce Apr 1989 A
4830002 Semm May 1989 A
4836205 Barrett Jun 1989 A
4845851 Warthen Jul 1989 A
4848341 Ahmad Jul 1989 A
4852568 Kensey Aug 1989 A
4890612 Kensey Jan 1990 A
4898155 Ovil et al. Feb 1990 A
4911164 Roth Mar 1990 A
4917089 Sideris Apr 1990 A
4926860 Stice et al. May 1990 A
4929246 Sinofsky May 1990 A
4935027 Yo on Jun 1990 A
4950285 Wilk Aug 1990 A
4957498 Caspari et al. Sep 1990 A
4966600 Songer et al. Oct 1990 A
4981149 Yoon et al. Jan 1991 A
4983168 Moorehead Jan 1991 A
4984581 Stice Jan 1991 A
5002563 Pyka et al. Mar 1991 A
5009643 Reich et al. Apr 1991 A
5021059 Kensey et al. Jun 1991 A
5037433 Wilk et al. Aug 1991 A
5041129 Hayhurst et al. Aug 1991 A
5047039 Avant et al. Sep 1991 A
5059201 Asnis Oct 1991 A
5061274 Kensey Oct 1991 A
5074874 Yoon et al. Dec 1991 A
5078721 McKeating Jan 1992 A
5080664 Jain Jan 1992 A
5089010 Korthoff Feb 1992 A
5100419 Ehlers Mar 1992 A
5100422 Berguer et al. Mar 1992 A
5100432 Matsutani Mar 1992 A
5108421 Fowler Apr 1992 A
5109780 Slouf et al. May 1992 A
5129882 Weldon et al. Jul 1992 A
5129912 Noda et al. Jul 1992 A
5129913 Ruppert Jul 1992 A
5144961 Chen et al. Sep 1992 A
5147373 Ferzli Sep 1992 A
5156788 Chesterfield et al. Oct 1992 A
5160339 Chen et al. Nov 1992 A
5163946 Li Nov 1992 A
5169041 Tan Dec 1992 A
5171251 Bregen et al. Dec 1992 A
5176691 Pierce Jan 1993 A
5178629 Kammerer Jan 1993 A
5192287 Fournier et al. Mar 1993 A
5192294 Blake, III Mar 1993 A
5192301 Kamiya et al. Mar 1993 A
5192302 Kensey et al. Mar 1993 A
5201744 Jones Apr 1993 A
5207703 Jain May 1993 A
5211650 Noda May 1993 A
5217470 Weston Jun 1993 A
5217471 Burkhart Jun 1993 A
5217485 Liv et al. Jun 1993 A
5219358 Bendel et al. Jun 1993 A
5222974 Kensey et al. Jun 1993 A
5234443 Phan et al. Aug 1993 A
5234445 Walker et al. Aug 1993 A
5237985 Hodgson et al. Aug 1993 A
5237996 Waldman et al. Aug 1993 A
5242427 Bilweis Sep 1993 A
5250033 Evans Oct 1993 A
5250053 Snyder Oct 1993 A
5250054 Li Oct 1993 A
5254105 Haaga Oct 1993 A
5254113 Wilk Oct 1993 A
5254126 Filipi et al. Oct 1993 A
5258003 Ciaglia et al. Nov 1993 A
5259846 Granger et al. Nov 1993 A
5275616 Fowler Jan 1994 A
5279311 Snyder Jan 1994 A
5281236 Bognato et al. Jan 1994 A
5281237 Gimpelson Jan 1994 A
5284485 Kammerer et al. Feb 1994 A
5285945 Brinkerhoff et al. Feb 1994 A
5289963 McGarry et al. Mar 1994 A
5290284 Adair Mar 1994 A
5290297 Phillips Mar 1994 A
5290310 Makower et al. Mar 1994 A
5292309 VanTassel et al. Mar 1994 A
5292327 Dodd et al. Mar 1994 A
5292332 Lee Mar 1994 A
5293881 Green et al. Mar 1994 A
5295993 Green Mar 1994 A
5300085 Yock Apr 1994 A
5304184 Hathaway et al. Apr 1994 A
5304185 Taylor Apr 1994 A
5306254 Nash et al. Apr 1994 A
5312024 Grant et al. May 1994 A
5312423 Rosenbluth et al. May 1994 A
5318578 Hasson Jun 1994 A
5320629 Noda et al. Jun 1994 A
5320632 Heidmueller Jun 1994 A
5330445 Haaga Jul 1994 A
5330491 Walker et al. Jul 1994 A
5334217 Das Aug 1994 A
5336229 Noda Aug 1994 A
5336230 Leichtling et al. Aug 1994 A
5336231 Adair Aug 1994 A
5342369 Harryman, II Aug 1994 A
5353974 Maurizio Oct 1994 A
5354279 Hoefling Oct 1994 A
5354312 Brinkerhoff et al. Oct 1994 A
5364407 Poll Nov 1994 A
5364408 Gordon Nov 1994 A
5368595 Lewis Nov 1994 A
5368601 Sauer et al. Nov 1994 A
5374275 Bradley et al. Dec 1994 A
5374278 Chesterfield et al. Dec 1994 A
5376096 Foster Dec 1994 A
5383896 Gershony et al. Jan 1995 A
5383905 Golds et al. Jan 1995 A
5385569 Swor Jan 1995 A
5387221 Bisgaard Feb 1995 A
5387227 Grice Feb 1995 A
5391176 de la Torre Feb 1995 A
5391182 Chin Feb 1995 A
5395332 Ressemann et al. Mar 1995 A
5395349 Quiachon et al. Mar 1995 A
5397310 Chu et al. Mar 1995 A
5397325 Delia Badia et al. Mar 1995 A
5397326 Mangum Mar 1995 A
5403329 Hinchcliffe Apr 1995 A
5403330 Tuason Apr 1995 A
5403331 Chesterfield et al. Apr 1995 A
5403338 Milo Apr 1995 A
5405352 Weston Apr 1995 A
5411481 Allen et al. May 1995 A
5413571 Katsaros et al. May 1995 A
5417684 Jackson et al. May 1995 A
5417699 Klein May 1995 A
5419765 Weldon et al. May 1995 A
5425705 Evard et al. Jun 1995 A
5425737 Burbank et al. Jun 1995 A
5425740 Hutchinson, Jr. Jun 1995 A
5431666 Sauer et al. Jul 1995 A
5433700 Peters Jul 1995 A
5452733 Sterman et al. Sep 1995 A
5454822 Schob et al. Oct 1995 A
5454834 Boebel et al. Oct 1995 A
5458574 Machold et al. Oct 1995 A
5458609 Gordon et al. Oct 1995 A
5462560 Stevens Oct 1995 A
5462561 Voda Oct 1995 A
5464426 Bonutti Nov 1995 A
5466241 Leroy et al. Nov 1995 A
5470338 Whitfield et al. Nov 1995 A
5474568 Scott Dec 1995 A
5476469 Hathaway et al. Dec 1995 A
5476470 Fitzgibbons, Jr. Dec 1995 A
5478309 Sweezer et al. Dec 1995 A
5478353 Yoon Dec 1995 A
5478354 Tovey et al. Dec 1995 A
5480407 Wan et al. Jan 1996 A
5486190 Green Jan 1996 A
5489295 Piplani et al. Feb 1996 A
5492119 Abrams Feb 1996 A
5496332 Sierra et al. Mar 1996 A
5507744 Tay et al. Apr 1996 A
5507755 Gresl et al. Apr 1996 A
5507757 Sauer et al. Apr 1996 A
5507758 Thomason et al. Apr 1996 A
5509902 Raulerson Apr 1996 A
5520655 Davila et al. May 1996 A
5520665 Fleetwood May 1996 A
5520691 Branch May 1996 A
5520702 Sauer et al. May 1996 A
5527321 Hinchliffe Jun 1996 A
5527322 Klein et al. Jun 1996 A
D372310 Hartnett Jul 1996 S
5531700 Moore et al. Jul 1996 A
5536267 Edwards et al. Jul 1996 A
5536273 Lehrer Jul 1996 A
5540701 Sharkey et al. Jul 1996 A
5540703 Barker, Jr. et al. Jul 1996 A
5540704 Gordon et al. Jul 1996 A
5545171 Sharkey et al. Aug 1996 A
5545178 Kensey et al. Aug 1996 A
5545180 Le et al. Aug 1996 A
5549618 Fleenor et al. Aug 1996 A
5549631 Bonutti Aug 1996 A
5554162 DeLange Sep 1996 A
5562684 Kammerer Oct 1996 A
5562686 Sauer et al. Oct 1996 A
5562688 Riza Oct 1996 A
5562728 Lazarus et al. Oct 1996 A
5567435 Hubbell et al. Oct 1996 A
5569269 Hart et al. Oct 1996 A
5569271 Hoel Oct 1996 A
5571120 Yoon Nov 1996 A
5573540 Yoon Nov 1996 A
5578044 Gordon et al. Nov 1996 A
5584842 Fogarty et al. Dec 1996 A
5591177 Lehrer Jan 1997 A
5591179 Edelstein Jan 1997 A
5591206 Moufarrege Jan 1997 A
5593421 Bauer Jan 1997 A
5601572 Middleman et al. Feb 1997 A
5603718 Xu Feb 1997 A
5607435 Sachdeva et al. Mar 1997 A
5609597 Lehrer Mar 1997 A
5611794 Sauer et al. Mar 1997 A
5613974 Andreas et al. Mar 1997 A
5613975 Christy Mar 1997 A
5624446 Harryman, II Apr 1997 A
5626588 Sauer et al. May 1997 A
5643289 Sauer et al. Jul 1997 A
5643295 Yoon Jul 1997 A
5643318 Tsukernik et al. Jul 1997 A
5647372 Tovey et al. Jul 1997 A
5649959 Hannam et al. Jul 1997 A
5653717 Ko et al. Aug 1997 A
5662664 Gordon et al. Sep 1997 A
5669917 Sauer et al. Sep 1997 A
5672174 Gough et al. Sep 1997 A
5674231 Green et al. Oct 1997 A
5676689 Kensey et al. Oct 1997 A
5693061 Pierce et al. Dec 1997 A
5700273 Buelna et al. Dec 1997 A
5707379 Fleenor et al. Jan 1998 A
5713899 Marnay et al. Feb 1998 A
5713910 Gordon et al. Feb 1998 A
5716369 Riza Feb 1998 A
5720574 Barella Feb 1998 A
5720757 Hathaway et al. Feb 1998 A
5722981 Stevens Mar 1998 A
5725552 Kotula et al. Mar 1998 A
5728109 Schulze et al. Mar 1998 A
5728114 Evans et al. Mar 1998 A
5728133 Kontos Mar 1998 A
5728143 Gough et al. Mar 1998 A
5728151 Garrison et al. Mar 1998 A
5741276 Poloyko et al. Apr 1998 A
5741280 Fleenor Apr 1998 A
5746755 Wood et al. May 1998 A
5749890 Shaknovich May 1998 A
5755727 Kontos May 1998 A
5759188 Yoon Jun 1998 A
5759189 Ferragamo et al. Jun 1998 A
5766183 Sauer Jun 1998 A
5766186 Faraz et al. Jun 1998 A
5766217 Christy Jun 1998 A
5769862 Kammerer et al. Jun 1998 A
5779719 Klein et al. Jul 1998 A
5782860 Epstein et al. Jul 1998 A
5782861 Cragg et al. Jul 1998 A
5792151 Heck et al. Aug 1998 A
5792152 Klein et al. Aug 1998 A
5797928 Kogasaka Aug 1998 A
5797929 Andreas et al. Aug 1998 A
5799661 Boyd et al. Sep 1998 A
5810849 Kontos Sep 1998 A
5810850 Hathaway et al. Sep 1998 A
5810884 Kim Sep 1998 A
5814069 Schulze et al. Sep 1998 A
5817113 Gifford, III et al. Oct 1998 A
5820631 Nobles Oct 1998 A
5824010 McDonald Oct 1998 A
5824111 Schall et al. Oct 1998 A
5830125 Scribner et al. Nov 1998 A
5836315 Benderev et al. Nov 1998 A
5836955 Buelna et al. Nov 1998 A
5836956 Buelna et al. Nov 1998 A
5846253 Buelna et al. Dec 1998 A
5848714 Robson et al. Dec 1998 A
5855576 Leveen et al. Jan 1999 A
5855585 Kontos Jan 1999 A
5860963 Azam et al. Jan 1999 A
5860990 Nobles et al. Jan 1999 A
5860991 Klein et al. Jan 1999 A
5861005 Kontos Jan 1999 A
5868762 Cragg et al. Feb 1999 A
5871490 Schulze et al. Feb 1999 A
5871502 Suryadevara Feb 1999 A
5873876 Christy Feb 1999 A
5876411 Kontos Mar 1999 A
5895404 Ruiz Apr 1999 A
5897487 Ouchi Apr 1999 A
5897564 Schulze et al. Apr 1999 A
5902311 Andreas et al. May 1999 A
5904597 Doi et al. May 1999 A
5904690 Middleman et al. May 1999 A
5904697 Gifford, III et al. May 1999 A
5906631 Imran May 1999 A
5919207 Taheri Jul 1999 A
5921994 Andreas et al. Jul 1999 A
5928266 Kontos Jul 1999 A
5951547 Gough et al. Sep 1999 A
5951590 Goldfarb Sep 1999 A
5954732 Hart et al. Sep 1999 A
5957936 Yoon et al. Sep 1999 A
5957937 Yoon Sep 1999 A
5957938 Zhu et al. Sep 1999 A
5964773 Greenstein Oct 1999 A
5964782 Lafontaine et al. Oct 1999 A
5972030 Garrison et al. Oct 1999 A
5976161 Kirsch et al. Nov 1999 A
5980517 Gough Nov 1999 A
5980539 Kontos Nov 1999 A
5993466 Yoon Nov 1999 A
5993476 Groiso Nov 1999 A
5997555 Kontos Dec 1999 A
6001109 Kontos Dec 1999 A
6009877 Edwards Jan 2000 A
6022372 Kontos Feb 2000 A
6024747 Kontos Feb 2000 A
6036699 Andreas et al. Mar 2000 A
6042601 Smith Mar 2000 A
6048351 Gordon et al. Apr 2000 A
6048354 Lawrence Apr 2000 A
6048357 Kontos Apr 2000 A
6056744 Edwards May 2000 A
6059800 Hart et al. May 2000 A
6068603 Suzuki May 2000 A
6077276 Kontos Jun 2000 A
6077279 Kontos Jun 2000 A
6083242 Cook Jul 2000 A
6102920 Sullivan et al. Aug 2000 A
6117144 Nobles et al. Sep 2000 A
6117145 Wood et al. Sep 2000 A
6126675 Shchervinsky et al. Oct 2000 A
6132439 Kontos Oct 2000 A
6132440 Hathaway et al. Oct 2000 A
6136010 Modesitt et al. Oct 2000 A
6139556 Kontos Oct 2000 A
6143004 Davis et al. Nov 2000 A
6152936 Christy et al. Nov 2000 A
6165183 Kuehn et al. Dec 2000 A
6165204 Levinson et al. Dec 2000 A
6190396 Whitin et al. Feb 2001 B1
6197042 Ginn et al. Mar 2001 B1
6206893 Klein et al. Mar 2001 B1
6206895 Levinson Mar 2001 B1
6221084 Fleenor Apr 2001 B1
6245079 Nobles Jun 2001 B1
6248124 Pedros et al. Jun 2001 B1
6296657 Brucker Oct 2001 B1
6302870 Jacobsen et al. Oct 2001 B1
6306081 Ishikawa et al. Oct 2001 B1
6322580 Kanner Nov 2001 B1
6346111 Gordon et al. Feb 2002 B1
6348059 Hathaway et al. Feb 2002 B1
6355050 Andreas et al. Mar 2002 B1
6358258 Arcia et al. Mar 2002 B1
6395015 Borst et al. May 2002 B1
6397110 Kuzma May 2002 B1
6428472 Haas Aug 2002 B1
6428549 Kontos Aug 2002 B1
6436109 Kontos Aug 2002 B1
6443963 Baldwin et al. Sep 2002 B1
6451031 Kontos Sep 2002 B1
6461366 Seguin Oct 2002 B1
6511489 Field et al. Jan 2003 B2
6517498 Burbank et al. Feb 2003 B1
6517553 Klein et al. Feb 2003 B2
6533812 Swanson et al. Mar 2003 B2
6551329 Kortenbach et al. Apr 2003 B1
6551330 Bain et al. Apr 2003 B1
6558399 Isbell et al. May 2003 B1
6562052 Nobles et al. May 2003 B2
6569159 Edwards et al. May 2003 B1
6569185 Ungs May 2003 B2
6572629 Kalloo et al. Jun 2003 B2
6610072 Christy et al. Aug 2003 B1
6623509 Ginn Sep 2003 B2
6623510 Carley et al. Sep 2003 B2
6626930 Allen Sep 2003 B1
6632237 Ben-David et al. Oct 2003 B2
6641592 Sauer et al. Nov 2003 B1
6663655 Ginn et al. Dec 2003 B2
6676685 Pedros et al. Jan 2004 B2
6695867 Ginn et al. Feb 2004 B2
6716228 Tal Apr 2004 B2
6743195 Zucker Jun 2004 B2
6743241 Kerr Jun 2004 B2
6743259 Ginn Jun 2004 B2
6745079 King Jun 2004 B2
6746457 Dana et al. Jun 2004 B2
6749621 Pantages et al. Jun 2004 B2
6749622 McGuckin, Jr. et al. Jun 2004 B2
6776785 Yencho et al. Aug 2004 B1
6837906 Ginn Jan 2005 B2
6846319 Ginn et al. Jan 2005 B2
6890343 Ginn et al. May 2005 B2
6896692 Ginn et al. May 2005 B2
6911034 Nobles et al. Jun 2005 B2
6936054 Chu Aug 2005 B2
6939357 Navarro et al. Sep 2005 B2
6955643 Gellman et al. Oct 2005 B2
6964668 Modesitt et al. Nov 2005 B2
6969371 Palasis et al. Nov 2005 B2
6969397 Ginn Nov 2005 B2
6997932 Dreyfuss et al. Feb 2006 B2
7001400 Modesitt et al. Feb 2006 B1
7029480 Klein et al. Apr 2006 B2
7029481 Burdulis, Jr. et al. Apr 2006 B1
7033370 Gordon et al. Apr 2006 B2
7048747 Arcia et al. May 2006 B2
7060084 Loshakove et al. Jun 2006 B1
7063710 Takamoto et al. Jun 2006 B2
7063711 Loshakove et al. Jun 2006 B1
7066077 Schnapp et al. Jun 2006 B2
7083635 Ginn Aug 2006 B2
7108710 Anderson Sep 2006 B2
7112225 Ginn Sep 2006 B2
7122002 Okada Oct 2006 B2
7131980 Field et al. Nov 2006 B1
7147646 Dana et al. Dec 2006 B2
7160309 Voss Jan 2007 B2
7179266 Kontos Feb 2007 B2
7229458 Boecker et al. Jun 2007 B2
7235087 Modesitt et al. Jun 2007 B2
7270672 Singer Sep 2007 B1
7316704 Bagaoisan et al. Jan 2008 B2
7326230 Ravikumar Feb 2008 B2
7331979 Khosravi et al. Feb 2008 B2
7335220 Khosravi et al. Feb 2008 B2
7361183 Ginn Apr 2008 B2
7361185 O'Malley et al. Apr 2008 B2
7377927 Burdulis, Jr. et al. May 2008 B2
7390328 Modesitt Jun 2008 B2
7393363 Ginn Jul 2008 B2
7431727 Cole et al. Oct 2008 B2
7442198 Gellman et al. Oct 2008 B2
7445626 Songer et al. Nov 2008 B2
7449024 Stafford Nov 2008 B2
7462188 McIntosh Dec 2008 B2
7507200 Okada Mar 2009 B2
7727249 Rahmani Jun 2010 B2
7753923 St. Goar et al. Jul 2010 B2
7833235 Chu Nov 2010 B2
7837696 Modesitt et al. Nov 2010 B2
7842047 Modesitt et al. Nov 2010 B2
7842048 Ma Nov 2010 B2
7842049 Voss Nov 2010 B2
7846170 Modesitt et al. Dec 2010 B2
7850701 Modesitt Dec 2010 B2
7883517 Pantages et al. Feb 2011 B2
7935128 Rioux et al. May 2011 B2
7967832 Chu Jun 2011 B2
8038688 Modesitt et al. Oct 2011 B2
8048092 Modesitt et al. Nov 2011 B2
8057491 Modesitt et al. Nov 2011 B2
8083754 Pantages et al. Dec 2011 B2
8123762 Chu et al. Feb 2012 B2
8137364 Zung et al. Mar 2012 B2
8172860 Zung et al. May 2012 B2
8202281 Voss Jun 2012 B2
8211122 McIntosh Jul 2012 B2
8252008 Ma Aug 2012 B2
8257368 McIntosh Sep 2012 B2
8267947 Pantages et al. Sep 2012 B2
8313498 Pantages et al. Nov 2012 B2
8323298 Modesitt et al. Dec 2012 B2
8361088 McIntosh Jan 2013 B2
8419753 Stafford Apr 2013 B2
8430893 Ma Apr 2013 B2
8512375 Torrie et al. Aug 2013 B2
8574244 Reynolds Nov 2013 B2
8597309 Stafford Dec 2013 B2
8663248 Zung et al. Mar 2014 B2
8663252 Fortson Mar 2014 B2
8858573 Fortson et al. Oct 2014 B2
8864778 Fortson et al. Oct 2014 B2
9241707 Roorda et al. Jan 2016 B2
9820730 Chu Nov 2017 B2
10426449 Fortson Oct 2019 B2
10426499 Owen et al. Oct 2019 B2
20010046518 Sawhney Nov 2001 A1
20020045908 Nobles et al. Apr 2002 A1
20020095164 Andreas et al. Jul 2002 A1
20020099389 Michler et al. Jul 2002 A1
20020106409 Sawhney et al. Aug 2002 A1
20020107531 Schreck et al. Aug 2002 A1
20020177876 Roby et al. Nov 2002 A1
20020188275 McGuckin Dec 2002 A1
20030093093 Modesitt et al. May 2003 A1
20030171764 Debbas Sep 2003 A1
20030195529 Takamoto et al. Oct 2003 A1
20030233095 Urbanski et al. Dec 2003 A1
20040009205 Sawhney Jan 2004 A1
20040021025 Shiga et al. Feb 2004 A1
20040092964 Modesitt et al. May 2004 A1
20040093027 Fabisiak et al. May 2004 A1
20040097978 Modesitt et al. May 2004 A1
20040127940 Ginn et al. Jul 2004 A1
20040143290 Brightbill Jul 2004 A1
20040158127 Okada Aug 2004 A1
20040158287 Cragg et al. Aug 2004 A1
20040167511 Buehlmann et al. Aug 2004 A1
20040181238 Zarbatany et al. Sep 2004 A1
20040186487 Klein et al. Sep 2004 A1
20040191277 Sawhney et al. Sep 2004 A1
20040215232 Belhe et al. Oct 2004 A1
20040225301 Roop et al. Nov 2004 A1
20040267193 Bagaoisan et al. Dec 2004 A1
20040267308 Bagaoisan et al. Dec 2004 A1
20050059982 Zung et al. Mar 2005 A1
20050070923 McIntosh Mar 2005 A1
20050075665 Brenzel et al. Apr 2005 A1
20050085851 Fiehler et al. Apr 2005 A1
20050085854 Ginn Apr 2005 A1
20050085855 Forsberg Apr 2005 A1
20050121042 Belhe et al. Jun 2005 A1
20050149066 Stafford Jul 2005 A1
20050149117 Khosravi et al. Jul 2005 A1
20050177189 Ginn et al. Aug 2005 A1
20050222614 Ginn et al. Oct 2005 A1
20050245876 Khosravi et al. Nov 2005 A1
20050267528 Ginn et al. Dec 2005 A1
20050273137 Ginn Dec 2005 A1
20060034930 Khosravi et al. Feb 2006 A1
20060047313 Khanna et al. Mar 2006 A1
20060069397 Nobles et al. Mar 2006 A1
20060089635 Young et al. Apr 2006 A1
20060095029 Young et al. May 2006 A1
20060100664 Pai et al. May 2006 A1
20060167477 Arcia et al. Jul 2006 A1
20060173469 Klein Aug 2006 A1
20060253037 Ginn et al. Nov 2006 A1
20060253072 Pai et al. Nov 2006 A1
20060259049 Harada et al. Nov 2006 A1
20070005079 Zarbatany et al. Jan 2007 A1
20070032801 Pantages et al. Feb 2007 A1
20070049967 Sibbitt et al. Mar 2007 A1
20070049968 Sibbitt et al. Mar 2007 A1
20070060895 Sibbitt et al. Mar 2007 A1
20070060950 Khosravi et al. Mar 2007 A1
20070123817 Khosravi et al. May 2007 A1
20070203506 Sibbitt et al. Aug 2007 A1
20070282354 McIntosh Dec 2007 A1
20080009794 Bagaoisan et al. Jan 2008 A1
20080065151 Ginn Mar 2008 A1
20080065152 Carley Mar 2008 A1
20080287967 Andreas et al. Nov 2008 A1
20090254119 Sibbitt et al. Oct 2009 A1
20100130965 Sibbitt et al. May 2010 A1
20110071567 Modesitt et al. Mar 2011 A1
20110077670 Modesitt et al. Mar 2011 A1
20110190793 Nobles Aug 2011 A1
20110288563 Gianotti et al. Nov 2011 A1
20120016383 Sauer Jan 2012 A1
20120150201 Pantages et al. Jun 2012 A1
20120283749 Sauer Nov 2012 A1
20120289903 Voss Nov 2012 A1
20130012962 Stone Jan 2013 A1
20130066340 Pantages et al. Mar 2013 A1
20130138122 McIntosh May 2013 A1
20130190781 Fortson et al. Jul 2013 A1
20130237999 Ma Sep 2013 A1
20140180312 Zung et al. Jun 2014 A1
20140222032 Stafford Aug 2014 A1
20140236189 Melsheimer et al. Aug 2014 A1
20150119906 Bagaoisan et al. Apr 2015 A1
20150273186 Voss Oct 2015 A1
20160135803 McIntosh May 2016 A1
20160135805 Roorda et al. May 2016 A1
20160192914 Ma Jul 2016 A1
20160287229 Zung et al. Oct 2016 A1
20180338759 Roorda et al. Nov 2018 A1
20190261964 Zung et al. Aug 2019 A1
20190357900 Stafford Nov 2019 A1
20200060664 Fortson et al. Feb 2020 A1
Foreign Referenced Citations (93)
Number Date Country
912619 May 1954 DE
4210724 Jul 1993 DE
9217932 Jul 1993 DE
4219724 Dec 1993 DE
4220283 Dec 1993 DE
10211360 Oct 2003 DE
0 140 557 May 1985 EP
0140757 May 1985 EP
0 207 545 Jan 1987 EP
0 474 887 Mar 1992 EP
0 478 358 Apr 1992 EP
0 478 887 Apr 1992 EP
0 542 126 May 1993 EP
0543499 May 1993 EP
0 568 098 Nov 1993 EP
0 589 409 Mar 1994 EP
0 624 343 Nov 1994 EP
0 669 101 Aug 1995 EP
0 669 102 Aug 1995 EP
0 669 103 Aug 1995 EP
0 684 012 Nov 1995 EP
0 812 571 Dec 1997 EP
0 941 698 Sep 1999 EP
0910288 Aug 2002 EP
1407557 Apr 2004 EP
1059544 Mar 1954 FR
2768324 Mar 1999 FR
51143386 Nov 1976 JP
52-020794 Feb 1977 JP
5220794 Feb 1977 JP
2119866 May 1990 JP
542161 Feb 1993 JP
820810 Apr 1981 SU
993922 Feb 1983 SU
1093329 May 1984 SU
1174036 Aug 1985 SU
1544383 Feb 1990 SU
1648400 May 1991 SU
WO 8503858 Sep 1985 WO
WO 0135833 Feb 1994 WO
WO 9405213 Mar 1994 WO
WO 9413211 Jun 1994 WO
WO 9427503 Dec 1994 WO
WO 9428801 Dec 1994 WO
WO 9505121 Feb 1995 WO
WO 9513021 May 1995 WO
WO 9525468 Sep 1995 WO
WO 9535065 Dec 1995 WO
WO 9609006 Mar 1996 WO
WO 9700046 Jan 1997 WO
WO 9703613 Feb 1997 WO
WO 9707745 Mar 1997 WO
WO 9710764 Mar 1997 WO
WO 9713461 Apr 1997 WO
WO 9717901 May 1997 WO
WO 9720505 Jun 1997 WO
WO 9727897 Aug 1997 WO
WO 9804195 Feb 1998 WO
WO 9842262 Oct 1998 WO
WO 9947049 Sep 1999 WO
WO 0012013 Mar 2000 WO
WO 0051498 Sep 2000 WO
WO 0069342 Nov 2000 WO
WO 0119259 Mar 2001 WO
WO 02036021 May 2002 WO
WO 02062234 Aug 2002 WO
0303598 Jan 2003 WO
WO 03003925 Jan 2003 WO
WO 03094748 Nov 2003 WO
WO 03099134 Dec 2003 WO
WO 05000126 Jan 2005 WO
WO 05023119 Mar 2005 WO
WO 05025430 Mar 2005 WO
WO 05030060 Apr 2005 WO
WO 05041782 May 2005 WO
WO 05063129 Jul 2005 WO
WO 05065549 Jul 2005 WO
WO 05092204 Oct 2005 WO
WO 05112782 Dec 2005 WO
WO 06026116 Mar 2006 WO
WO 06052611 May 2006 WO
WO 06052612 May 2006 WO
WO 06078578 Jul 2006 WO
WO 06115901 Nov 2006 WO
WO 06115904 Nov 2006 WO
WO 06118877 Nov 2006 WO
WO 07019016 Feb 2007 WO
2007025014 Mar 2007 WO
2007025017 Mar 2007 WO
2007025018 Mar 2007 WO
2007025019 Mar 2007 WO
WO 07081836 Jul 2007 WO
2010031050 Mar 2010 WO
Non-Patent Literature Citations (359)
Entry
US 5,820,544 A, 10/1998, NAME DATE (withdrawn)
U.S. Appl. No. 60/506,536, filed Sep. 26, 2003, McIntosh.
U.S. Appl. No. 60/540,811, filed Jan. 30, 2004, McIntosh.
U.S. Appl. No. 60/946,063, filed Jun. 25, 2007, Reynolds.
U.S. Appl. No. 90/006,469, filed Nov. 29, 2002, Modesitt, et al.
Cardiac Catheterization and Angiography, 3rd Ed., Lea & Febiger, Philadelphia, pp. 1-49, 52-247. 1986.
Cardio-Thoracic Systems Prospectus dated Mar. 20, 1996. pp. 1-4, 25-40.
Datascope Corporation, Montvale, NJ, Nov. 1991; 1 PG, American Heart Assoc. Meeting, Anaheim.
Elgiloy Brochure, Jun. 23, 1959; Elgin National Watch Co., Elgin, IL.
Kensey Nash Corporation, Exton, PA, “The Hemostatic Puncture Closure Device”, retrieved Oct. 23, 2007, 2 pages.
Laurus Medical Corporation, “Endoscopic Suturing Made Simple,” The Laurus ND-2600 Needle Driver, Irvine, CA., Oct. 1994, 1 page.
Marshall, A.C. & Lock, J.E.; “Structural and compliant anatomy of the patent foramen ovale in patients undergoing transcatheter closure”, Am. Heart Journ., 140(2):303-307, Aug. 2000.
Nakamura, S. et al., Techniques for Palmaz-Schatz Stent Deployment in Lesions With A Large Side Branch, Catheterization and Cardiovascular Diagnosis, 34: 353-361, 1995.
Definition of “pair”, Dictionary.com, accessed on May 5, 2014.
Product Brochure, “SuperStitch—Closure Made SimpleTM”, Sutura, Inc. (2003).
Product Brochure, Laurus Medical Corporation, Irvine, CA “The Laurus In-Line Endoscopic Suturing Device” (Oct. 1994) 1 page.
Rema-Medizintcchnik GmbH, Product Brochure entitled “REMA,” Apr. 2001, 7 pages.
Serruys, PW et al., A Comparision Of Balloon-Expandable-Stent Implantation With Balloon Angioplasty In Patients With Coronary Artery Disease, New England Journal of Medicine, 331:489-495, 1994.
Taber's Cyclopedic Medical Dictionary, 18th Ed., p. 747, Feb. 1997.
U.S. Appl. No. 07/989,611, May 12, 1993, Office Action.
U.S. Appl. No. 07/989,611, Aug. 1, 1994, Office Action.
U.S. Appl. No. 07/989,611, Nov. 3, 1994, Notice of Allowance.
U.S. Appl. No. 08/148,809, Sep. 16, 1994, Office Action.
U.S. Appl. No. 08/148,809, May 30, 1995, Office Action.
U.S. Appl. No. 08/148,809, Dec. 15, 1995, Notice of Allowance.
U.S. Appl. No. 08/252,124, Jun. 5, 1995, Office Action.
U.S. Appl. No. 08/252,124, Jan. 5, 1996, Office Action.
U.S. Appl. No. 08/252,124, May 22, 1996, Notice of Allowance.
U.S. Appl. No. 08/259,410, Feb. 2, 1995, Office Action.
U.S. Appl. No. 08/259,410, Jun. 1, 1995, Office Action.
U.S. Appl. No. 08/259,410, Feb. 6, 1998, Notice of Allowance.
U.S. Appl. No. 08/638,076, Jan. 21, 1997, Office Action.
U.S. Appl. No. 08/638,076, Oct. 17, 1997, Notice of Allowance.
U.S. Appl. No. 08/824,031, Mar. 16, 1998, Office Action.
U.S. Appl. No. 08/824,031, Sep. 14, 1998, Office Action.
U.S. Appl. No. 08/824,031, Apr. 13, 1999, Office Action.
U.S. Appl. No. 08/824,031, Jul. 15, 1999, Notice of Allowance.
U.S. Appl. No. 08/883,246, Jul. 23, 1998, Office Action.
U.S. Appl. No. 08/883,246, Apr. 12, 1999, Office Action.
U.S. Appl. No. 08/883,246, Oct. 13, 1999, Office Action.
U.S. Appl. No. 08/883,246, Oct. 23, 2000, Office Action.
U.S. Appl. No. 08/883,246, Jul. 11, 2001, Office Action.
U.S. Appl. No. 08/883,246, Sep. 11, 2001, Notice of Allowance.
U.S. Appl. No. 09/057,108, Jul. 10, 2000, Office Action.
U.S. Appl. No. 09/057,108, Oct. 25, 2000, Notice of Allowance.
U.S. Appl. No. 09/262,402, Mar. 29, 2000, Office Action.
U.S. Appl. No. 09/262,402, May 30, 2000, Notice of Allowance.
U.S. Appl. No. 09/395,901, Jun. 27, 2000, Office Action.
U.S. Appl. No. 09/395,901, Nov. 6, 2000, Office Action.
U.S. Appl. No. 09/395,901, Apr. 20, 2001, Notice of Allowance.
U.S. Appl. No. 09/395,901, Sep. 10, 2001, Notice of Allowance.
U.S. Appl. No. 09/610,099, Jul. 11, 2002, Office Action.
U.S. Appl. No. 09/610,099, Dec. 24, 2002, Notice of Allowance.
U.S. Appl. No. 09/651,344, Feb. 28, 2003, Office Action.
U.S. Appl. No. 09/651,344, Nov. 7, 2003, Office Action.
U.S. Appl. No. 09/651,344, Apr. 20, 2004, Notice of Allowance.
U.S. Appl. No. 09/707,746, Feb. 16, 2005, Office Action.
U.S. Appl. No. 09/707,746, Jul. 7, 2005, Office Action.
U.S. Appl. No. 09/707,746, Nov. 15, 2005, Notice of Allowance.
U.S. Appl. No. 09/769,109, Oct. 23, 2001, Office Action.
U.S. Appl. No. 09/769,109, Jun. 17, 2002, Office Action.
U.S. Appl. No. 09/769,109, Sep. 9, 2002, Notice of Allowance.
U.S. Appl. No. 09/988,541, Mar. 17, 2004, Office Action.
U.S. Appl. No. 09/988,541, Feb. 28, 2005, Office Action.
U.S. Appl. No. 09/988,541, May 25, 2005, Office Action.
U.S. Appl. No. 09/988,541, Aug. 24, 2005, Office Action.
U.S. Appl. No. 09/988,541, Nov. 8, 2005, Office Action.
U.S. Appl. No. 09/988,541, Dec. 13, 2005, Notice of Allowance.
U.S. Appl. No. 10/033,689, Sep. 30, 2003, Office Action.
U.S. Appl. No. 10/152,272, Jan. 24, 2005, Office Action.
U.S. Appl. No. 10/152,272, May 13, 2005, Notice of Allowance.
U.S. Appl. No. 10/335,065, Mar. 17, 2005, Office Action.
U.S. Appl. No. 10/335,065, Jun. 10, 2005, Office Action.
U.S. Appl. No. 10/335,065, Nov. 17, 2005, Notice of Allowance.
U.S. Appl. No. 10/335,147, Dec. 13, 2005, Office Action.
U.S. Appl. No. 10/335,147, Apr. 17, 2006, Office Action.
U.S. Appl. No. 10/335,147, Oct. 4, 2006, Notice of Allowance.
U.S. Appl. No. 10/357,984, Jan. 9, 2006, Office Action.
U.S. Appl. No. 10/357,984, Mar. 16, 2006, Office Action.
U.S. Appl. No. 10/357,984, Sep. 28, 2006, Office Action.
U.S. Appl. No. 10/357,984, Mar. 23, 2007, Office Action.
U.S. Appl. No. 10/357,984, Nov. 14, 2007, Office Action.
U.S. Appl. No. 10/652,182, Aug. 9, 2006, Office Action.
U.S. Appl. No. 10/652,182, Feb. 22, 2007, Notice of Allowance.
U.S. Appl. No. 10/660,288, Nov. 15, 2005, Office Action.
U.S. Appl. No. 10/660,288, Mar. 9, 2006, Office Action.
U.S. Appl. No. 10/660,288, Aug. 24, 2006, Office Action.
U.S. Appl. No. 10/660,288, Feb. 1, 2007, Office Action.
U.S. Appl. No. 10/660,288, Jun. 28, 2007, Office Action.
U.S. Appl. No. 10/660,288, Apr. 29, 2009, Office Action.
U.S. Appl. No. 10/660,288, Aug. 3, 2009, Office Action.
U.S. Appl. No. 10/660,288, Mar. 30, 2010, Office Action.
U.S. Appl. No. 10/660,288, Mar. 29, 2011, Office Action.
U.S. Appl. No. 10/660,288, Sep. 30, 2011, Notice of Allowance.
U.S. Appl. No. 10/729,541, Dec. 12, 2006, Office Action.
U.S. Appl. No. 10/729,541, Jun. 18, 2007, Office Action.
U.S. Appl. No. 10/729,541, Jan. 8, 2008, Office Action.
U.S. Appl. No. 10/729,541, Sep. 23, 2008, Office Action.
U.S. Appl. No. 10/729,541, May 1, 2009, Office Action.
U.S. Appl. No. 10/729,541, Nov. 16, 2009, Notice of Allowance.
U.S. Appl. No. 10/729,541, Mar. 25, 2010, Notice of Allowance.
U.S. Appl. No. 10/729,541, Jul. 12, 2010, Notice of Allowance.
U.S. Appl. No. 10/737,668, Nov. 2, 2005, Office Action.
U.S. Appl. No. 10/737,668, Feb. 16, 2006, Office Action.
U.S. Appl. No. 10/737,668, Oct. 19, 2006, Office Action.
U.S. Appl. No. 10/737,668, Jun. 7, 2007, Office Action.
U.S. Appl. No. 10/737,668, Nov. 28, 2007, Office Action.
U.S. Appl. No. 10/737,668, Jun. 26, 2008, Notice of Allowance.
U.S. Appl. No. 10/742,406, Mar. 23, 2007, Office Action.
U.S. Appl. No. 10/742,406, Sep. 10, 2007, Notice of Allowance.
U.S. Appl. No. 10/742,406, Jan. 11, 2008, Notice of Allowance.
U.S. Appl. No. 10/746,210, Apr. 5, 2007, Office Action.
U.S. Appl. No. 10/746,210, Aug. 21, 2007, Office Action.
U.S. Appl. No. 10/746,210, Jul. 9, 2008, Notice of Allowance.
U.S. Appl. No. 10/813,449, Sep. 5, 2006, Office Action.
U.S. Appl. No. 10/813,449, Jul. 16, 2007, Office Action.
U.S. Appl. No. 10/813,449, Jan. 25, 2008, Office Action.
U.S. Appl. No. 10/813,449, Aug. 14, 2008, Office Action.
U.S. Appl. No. 10/813,449, Sep. 15, 2008, Office Action.
U.S. Appl. No. 10/813,449, Feb. 3, 2009, Office Action.
U.S. Appl. No. 10/813,449, Aug. 28, 2009, Office Action.
U.S. Appl. No. 10/813,449, May 27, 2010, Office Action.
U.S. Appl. No. 10/909,531, Apr. 4, 2007, Office Action.
U.S. Appl. No. 10/909,531, Dec. 26, 2007, Office Action.
U.S. Appl. No. 10/909,531, Jun. 13, 2008, Office Action.
U.S. Appl. No. 10/909,531, Feb. 9, 2009, Office Action.
U.S. Appl. No. 10/909,531, Sep. 16, 2009, Office Action.
U.S. Appl. No. 10/909,531, Apr. 29, 2010, Notice of Allowance.
U.S. Appl. No. 10/909,531, Aug. 20, 2010, Notice of Allowance.
U.S. Appl. No. 10/948,445, Jul. 11, 2007, Office Action.
U.S. Appl. No. 11/199,338, Jan. 25, 2007, Office Action.
U.S. Appl. No. 11/199,338, Oct. 5, 2007, Office Action.
U.S. Appl. No. 11/199,338, Dec. 28, 2007, Office Action.
U.S. Appl. No. 11/199,338, Apr. 23, 2008, Office Action.
U.S. Appl. No. 11/199,338, Jan. 6, 2009, Office Action.
U.S. Appl. No. 11/199,496, Apr. 1, 2009, Office Action.
U.S. Appl. No. 11/199,496, Aug. 21, 2009, Office Action.
U.S. Appl. No. 11/199,496, Apr. 23, 2010, Office Action.
U.S. Appl. No. 11/199,496, Apr. 28, 2011, Office Action.
U.S. Appl. No. 11/199,496, Aug. 18, 2011, Notice of Allowance.
U.S. Appl. No. 11/199,515, Aug. 20, 2008, Office Action.
U.S. Appl. No. 11/199,515, Nov. 13, 2008, Office Action.
U.S. Appl. No. 11/199,515, Jun. 10, 2009, Office Action.
U.S. Appl. No. 11/199,515, Dec. 24, 2009, Notice of Allowance.
U.S. Appl. No. 11/199,515, Apr. 2, 2010, Notice of Allowance.
U.S. Appl. No. 11/199,515, Aug. 2, 2010, Notice of Allowance.
U.S. Appl. No. 11/273,107, Jun. 14, 2007, Office Action.
U.S. Appl. No. 11/273,107, Jan. 18, 2008, Office Action.
U.S. Appl. No. 11/273,107, Sep. 5, 2008, Office Action.
U.S. Appl. No. 11/273,107, Apr. 9, 2009, Office Action.
U.S. Appl. No. 11/273,107, Oct. 28, 2009, Office Action.
U.S. Appl. No. 11/273,107, Jun. 2, 2010, Office Action.
U.S. Appl. No. 11/273,107, Oct. 27, 2010, Office Action.
U.S. Appl. No. 11/273,107, Jun. 2, 2011, Notice of Allowance.
U.S. Appl. No. 11/363,005, Jun. 22, 2007, Office Action.
U.S. Appl. No. 11/363,005, Dec. 14, 2007, Office Action.
U.S. Appl. No. 11/363,005, Apr. 17, 2008, Office Action.
U.S. Appl. No. 11/363,005, Dec. 23, 2008, Office Action.
U.S. Appl. No. 11/363,005, Jul. 10, 2009, Notice of Allowance.
U.S. Appl. No. 11/363,005, Jan. 14, 2010, Notice of Allowance.
U.S. Appl. No. 11/363,005, Jul. 23, 2010, Notice of Allowance.
U.S. Appl. No. 11/389,762, Sep. 20, 2007, Notice of Allowance.
U.S. Appl. No. 11/389,762, Nov. 23, 2007, Notice of Allowance.
U.S. Appl. No. 11/390,937, Sep. 7, 2007, Office Action.
U.S. Appl. No. 11/391,951, Oct. 28, 2008, Office Action.
U.S. Appl. No. 11/391,951, Jan. 30, 2009, Office Action.
U.S. Appl. No. 11/391,951, Aug. 26, 2009, Office Action.
U.S. Appl. No. 11/391,951, Jun. 23, 2010, Office Action.
U.S. Appl. No. 11/465,527, Feb. 3, 2010, Office Action.
U.S. Appl. No. 11/465,527, Jul. 23, 2010, Notice of Allowance.
U.S. Appl. No. 11/552,593, Aug. 21, 2008, Office Action.
U.S. Appl. No. 11/552,593, Feb. 5, 2009, Office Action.
U.S. Appl. No. 11/552,593, Oct. 13, 2009, Notice of Allowance.
U.S. Appl. No. 11/552,593, Mar. 22, 2010, Notice of Allowance.
U.S. Appl. No. 11/552,593, Jul. 22, 2010, Notice of Allowance.
U.S. Appl. No. 11/688,722, Mar. 10, 2010, Office Action.
U.S. Appl. No. 11/688,722, Jul. 29, 2010, Notice of Allowance.
U.S. Appl. No. 11/891,358, Apr. 26, 2010, Office Action.
U.S. Appl. No. 11/891,358, Oct. 19, 2010, Office Action.
U.S. Appl. No. 11/891,358, Aug. 31, 2011, Office Action.
U.S. Appl. No. 11/891,358, Nov. 18, 2011, Notice of Allowance.
U.S. Appl. No. 11/891,358, Apr. 10, 2012, Notice of Allowance.
U.S. Appl. No. 11/891,513, Apr. 9, 2010, Office Action.
U.S. Appl. No. 11/891,513, Sep. 28, 2010, Office Action.
U.S. Appl. No. 11/891,513, Aug. 31, 2011, Office Action.
U.S. Appl. No. 11/891,513, Nov. 1, 2011, Notice of Allowance.
U.S. Appl. No. 11/891,513, May 8, 2012, Notice of Allowance.
U.S. Appl. No. 11/960,593, Sep. 14, 2010, Office Action.
U.S. Appl. No. 11/960,593, Nov. 3, 2010, Office Action.
U.S. Appl. No. 11/960,593, Apr. 28, 2011, Office Action.
U.S. Appl. No. 11/960,593, Jul. 1, 2013, Notice of Allowance.
U.S. Appl. No. 11/997,379, Jul. 13, 2011, Office Action.
U.S. Appl. No. 11/997,379, Feb. 28, 2012, Office Action.
U.S. Appl. No. 11/997,379, May 11, 2012, Notice of Allowance.
U.S. Appl. No. 12/182,836, Oct. 5, 2010, Office Action.
U.S. Appl. No. 12/182,836, Jun. 23, 2011, Office Action.
U.S. Appl. No. 12/182,836, May 17, 2013, Office Action.
U.S. Appl. No. 12/247,012, Oct. 13, 2011, Office Action.
U.S. Appl. No. 12/247,012, Mar. 16, 2012, Office Action.
U.S. Appl. No. 12/247,012, Aug. 13, 2012, Notice of Allowance.
U.S. Appl. No. 12/257,127, Aug. 30, 2010, Office Action.
U.S. Appl. No. 12/257,127, Dec. 22, 2010, Office Action.
U.S. Appl. No. 12/257,127, Jul. 6, 2011, Office Action.
U.S. Appl. No. 12/257,127, Jan. 12, 2012, Office Action.
U.S. Appl. No. 12/257,127, Sep. 20, 2012, Notice of Allowance.
U.S. Appl. No. 12/334,077, Oct. 27, 2010, Office Action.
U.S. Appl. No. 12/334,077, Jul. 21, 2011, Office Action.
U.S. Appl. No. 12/334,077, Jan. 16, 2013, Office Action.
U.S. Appl. No. 12/334,077, Oct. 11, 2013, Notice of Allowance.
U.S. Appl. No. 12/334,085, Dec. 23, 2010, Office Action.
U.S. Appl. No. 12/334,085, Aug. 4, 2011, Office Action.
U.S. Appl. No. 12/334,085, Jan. 9, 2012, Notice of Allowance.
U.S. Appl. No. 12/873,728, Sep. 11, 2012, Office Action.
U.S. Appl. No. 12/873,728, May 3, 2013, Office Action.
U.S. Appl. No. 12/873,728, Aug. 23, 2013, Office Action.
U.S. Appl. No. 12/873,728, Nov. 4, 2013, Notice of Allowance.
U.S. Appl. No. 12/950,338, Jun. 15, 2011, Office Action.
U.S. Appl. No. 12/950,338, Nov. 1, 2011, Notice of Allowance.
U.S. Appl. No. 12/950,338, Aug. 8, 2012, Notice of Allowance.
U.S. Appl. No. 12/955,848, Jun. 30, 2011, Office Action.
U.S. Appl. No. 12/955,848, Nov. 15, 2011, Office Action.
U.S. Appl. No. 12/955,863, Jan. 6, 2012, Office Action.
U.S. Appl. No. 12/955,863, May 15, 2012, Notice of Allowance.
U.S. Appl. No. 12/955,869, Oct. 18, 2011, Office Action.
U.S. Appl. No. 12/955,869, Mar. 22, 2012, Notice of Allowance.
U.S. Appl. No. 12/961,239, Jul. 26, 2011, Notice of Allowance.
U.S. Appl. No. 12/966,961, Aug. 18, 2011, Notice of Allowance.
U.S. Appl. No. 13/022,050, Jul. 11, 2011, Office Action.
U.S. Appl. No. 13/022,050, Apr. 26, 2012, Office Action.
U.S. Appl. No. 13/022,050, Jul. 6, 2012, Notice of Allowance.
U.S. Appl. No. 13/333,411, Dec. 18, 2014, Office Action.
U.S. Appl. No. 13/443,659, Nov. 13, 2013, Office Action.
U.S. Appl. No. 13/443,659, Jun. 11, 2014, Notice of Allowance.
U.S. Appl. No. 13/455,053, Nov. 27, 2013, Office Action.
U.S. Appl. No. 13/455,053, Jun. 9, 2014, Notice of Allowance.
U.S. Appl. No. 13/525,875, May 28, 2014, Office Action.
U.S. Appl. No. 13/525,875, Sep. 30, 2014, Office Action.
U.S. Appl. No. 13/525,875, Dec. 10, 2014, Notice of Allowance.
U.S. Appl. No. 13/593,154, Jan. 8, 2013, Notice of Allowance.
U.S. Appl. No. 13/615,530, Jan. 17, 2013, Office Action.
U.S. Appl. No. 13/615,530, Jun. 12, 2013, Notice of Allowance.
U.S. Appl. No. 13/752,095, Oct. 17, 2014, Office Action.
U.S. Appl. No. 14/094,352, Dec. 15, 2014, Office Action.
U.S. Appl. No. 14/195,308, Dec. 18, 2014, Office Action.
U.S. Appl. No. 90/006,469, Nov. 29, 2002, Request for Re-Examination.
U.S. Appl. No. 90/006,469, Sep. 10, 2004, Office Action.
U.S. Appl. No. 90/006,469, Sep. 27, 2005, Notice of Re-Issue.
U.S. Appl. No. 90/006,469, Jun. 27, 2006, Re-Examination Certification.
U.S. Appl. No. 15/186,730, Jun. 20, 2016, Fortson et al.
U.S. Appl. No. 15/192,481, Jun. 24, 2016, Stafford.
U.S. Appl. No. 13/333,411, Apr. 1, 2015, Office Action.
U.S. Appl. No. 13/333,411, Apr. 4, 2016, Office Action.
U.S. Appl. No. 13/485,388, May 21, 2015, Office Action.
U.S. Appl. No. 13/485,388, Oct. 7, 2015, Notice of Allowance.
U.S. Appl. No. 13/615,523, Feb. 26, 2016, Office Action.
U.S. Appl. No. 13/615,523, Aug. 18, 2016, Office Action.
U.S. Appl. No. 13/752,095, Feb. 20, 2015, Office Action.
U.S. Appl. No. 13/752,095, Jun. 12, 2015, Notice of Allowance.
U.S. Appl. No. 13/791,858, Nov. 10, 2015, Office Action.
U.S. Appl. No. 13/791,858, Mar. 15, 2016, Notice of Allowance.
U.S. Appl. No. 13/870,628, Jul. 13, 2015, Office Action.
U.S. Appl. No. 13/870,628, Nov. 12, 2015, Notice of Allowance.
U.S. Appl. No. 14/094,352, Jul. 8, 2015, Office Action.
U.S. Appl. No. 14/094,352, Mar. 22, 2016, Notice of Allowance.
U.S. Appl. No. 14/195,308, Aug. 11, 2015, Office Action.
U.S. Appl. No. 14/195,308, Dec. 4, 2015, Notice of Allowance.
U.S. Appl. No. 13/615,523, Nov. 30, 2016, Notice of Allowance.
U.S. Appl. No. 14/674,756, Mar. 17, 2017, Office Action.
U.S. Appl. No. 15/434,907, Feb. 16, 2017, Aaron M. Fortson.
U.S. Appl. No. 14/674,756, Jul. 6, 2017, Office Action.
U.S. Appl. No. 14/674,756, Sep. 18, 2017, Notice of Allowance.
U.S. Appl. No. 14/880,894, Oct. 31, 2017, Office Action.
U.S. Appl. No. 15/005,880, Nov. 13, 2017, Office Action.
U.S. Appl. No. 15/069,515, Mar. 20, 2018, Notice of Allowance.
U.S. Appl. No. 14/880,894, Aug. 6, 2018, Office Action.
U.S. Appl. No. 15/005,880, Jun. 20, 2018, Interview Summary.
U.S. Appl. No. 15/005,880, Jul. 13, 2018, Notice of Allowance.
U.S. Appl. No. 15/186,730, Sep. 5, 2018, Office Action.
U.S. Appl. No. 15/192,481, Jul. 20, 2018, Office Action.
U.S. Appl. No. 14/880,894, Apr. 2, 2018, Office Action.
U.S. Appl. No. 15/005,880, Apr. 10, 2018, Office Action.
U.S. Appl. No. 15/069,515, May 23, 2018, Issue Notification.
U.S. Appl. No. 16/279,562, Feb. 19, 2019, McIntosh.
U.S. Appl. No. 15/186,730, Mar. 21, 2019, Office Action.
U.S. Appl. No. 15/192,481, May 6, 2019, Notice of Allowance.
U.S. Appl. No. 15/434,907, May 7, 2019, Notice of Allowance.
U.S. Appl. No. 14/880,894, Nov. 21, 2018, Notice of Allowance.
U.S. Appl. No. 15/090,150, Dec. 12, 2018, Office Action.
U.S. Appl. No. 15/192,481, Oct. 31, 2018, Interview Summary.
U.S. Appl. No. 15/192,481, Jan. 11, 2019, Office Action.
U.S. Appl. No. 15/090,150, Jul. 5, 2019, OA.
U.S. Appl. No. 15/186,730, Jul. 1, 2019, NOA.
U.S. Appl. No. 15/434,907, Sep. 11, 2019, IN.
“Innovation Through Progress”, Rema-Medizintechnik GmbH, Jan. 1992.
“The Hemostatic Puncture Closure Device,” Kensey Nash Corporation. (undated).
AD: The Laurus In-Line Endoscopic Suturing Device (The Laurus ND-2600 Needle Driver), Laurus Medical Corp., Rev. Oct. 1994.
Elgin National Watch Company, Product Borchure entitled “Elgiloy, A Cobalt Nickel Spring Alloy”, 33 pages, 1959.
Ernst, J. et al., “Immediate Sealing of Arterial Puncture Sites After Catheterization and PTCA Using a Vascular Hemostasis Device With Collagen: An International Registry.”(undated).
Faulkner, Catherine B., Letter regarding “VasoSeal Vascular Hemostasis”, Datascope, New Jersey, 1 page, (1991).
Grossman, William. Cardiac Catheterization and Angioplasty, 3rd Ed., Lea and Febiger. Philadelphia: 1986.
Merino, A. et al., “A Vascular Hemostasis Device for Percutaneous Interventional Procedures,” Mount Sinai Medical Center, N.Y. (undated).
Notice of Allowance received for U.S. Appl. No. 11/389,762, dated Nov. 23, 2007.
Notice of Allowance received for U.S. Patent No. 2006/0167476 dated Sep. 20, 2007.
Notice of Allowance received for U.S. Pat. No. 5,613,974 dated May 22, 1996.
Notice of Allowance received for U.S. Pat. No. 5,779,719 dated Feb. 6, 1998.
Notice of Allowance received for U.S. Pat. No. 6,517,553 dated Sep. 9, 2002.
Notice of Allowance received for U.S. Pat. No. 7,029,480 dated Nov. 17, 2005.
Office Action received for U.S. Appl. No. 07/989,611, dated Aug. 1, 1994.
Office action received for U.S. Appl. No. 10/877,974, dated Jul. 9, 2008.
Office action received for U.S. Appl. No. 11/316,775, dated Apr. 16, 2008.
Office action received for U.S. Appl. No. 11/316,775, dated Aug. 6, 2008.
Office action received for U.S. Appl. No. 11/508,656, dated Aug. 30, 2010.
Office Action received for U.S. Appl. No. 11/508,656, dated Dec. 9, 2009.
Office action received for U.S. Appl. No. 11/508,656, dated Mar. 25, 2010.
Office action received for U.S. Appl. No. 11/508,662, dated Apr. 14, 2010.
Office action received for U.S. Appl. No. 11/508,715, dated Apr. 26, 2010.
Office Action received for U.S. Appl. No. 11/508,715, dated Jan. 6, 2010.
Office Action received for U.S. Pat. No. 6,206,893 dated Jul. 10, 2000.
Office Action received for U.S. Pat. No. 7,029,480 dated Jun. 10, 2005.
Office Action received for U.S. Pat. No. 7,029,481 dated Feb. 16, 2005.
Office Action, dated Aug. 9, 2006, U.S. Pat. No. 7,235,087.
Product Brochure “The Proven Solution to Endoscopic Suturing”, Lamus Medical Corp., Irvine, CA (Oct. 1994).
Rema-Medizintechnik, Gmbh, “Innovation Through Progress,” Jan. 1992, pp. 1-8.
Request for Re-Examination received for U.S. Appl. No. 90/006,469, dated Nov. 29, 2002.
The Lamus In-Line Endoscopic Suturing Device (Oct. 1994) 1 page.
U.S. Appl. filed Apr. 24, 2012, Fortson et al., U.S. Appl. No. 13/445,053.
U.S. Appl. filed Aug. 24, 2005, Sibbitt, JR et al, U.S. Appl. No. 60/711,279.
U.S. Appl. filed Jun. 30, 2000, Burdulis., U.S. Appl. No. 09/608,832.
U.S. Appl. filed Jun. 30, 2000, Burdulis., U.S. Appl. No. 09/610,564.
U.S. Appl. filed Oct. 14, 2005, Sibbitt Jr. et al, U.S. Appl. No. 60/726,985.
U.S. Appl. filed Sep. 15, 2008, Sibbitt Jr. et al, U.S. Appl. No. 61/097,072.
U.S. Appl. No. 09/395,901, filed Apr. 20, 2001, Notice of Allowance.
U.S. Appl. No. 11/508,662, filed Oct. 26, 2010, Office Action.
U.S. Appl. No. 11/508,715, filed Oct. 18, 2010, Office Action.
U.S. Appl. No. 12/365,397, filed Sep. 13, 2010, Office Action.
U.S. Application filed on Nov. 29, 2007, by Modesitt et al., U.S. Appl. No. 90/006,469.
U.S. Provisional Application filed on Jan. 30, 2004, by McIntosh, U.S. Appl. No. 60/540,811.
Marshall, A.C. & Lock, J.E.; “Structural and compliant anatomy of the patent foramen ovale in patients undergoing transcatheter closure”, Am. Heart Joum., 140(2):303-307, Aug. 2000.
Notice of Allowance received for U.S. Pat. No. 5,792,152 dated Oct. 17, 1997.
Notice of Allowance received for U.S. Pat. No. 6,206,893 dated Oct. 25, 2000.
Notice of Allowance received for U.S. Pat. No. 6,355,050 dated Sep. 11, 2001.
Notice of Allowance received for U.S. Pat. No. 6,358,258 dated Apr. 20, 2001.
Notice of Allowance received for U.S. Pat. No. 6,358,258 dated Sep. 10, 2001.
Notice of Allowance received for U.S. Pat. No. 6,558,399 dated Dec. 24, 2002.
Office Ac tion received for U.S. Pat. No. 6,036,699, dated Sep. 14, 1998.
Office Action received for U.S. Pat. No. 5,613,974 dated Jan. 5, 1996.
Office Action received for U.S. Pat. No. 5,613,974 dated Jun. 5, 1995.
Office Action received for U.S. Pat. No. 5,779,719 dated Jun. 1, 1995.
Office Action received for U.S. Pat. No. 5,792,152 dated Jan. 21, 1997.
Office Action received for U.S. Pat. No. 6,036,699 dated Apr. 13, 1999.
Office Action received for U.S. Pat. No. 6,355,050 dated Jul. 11, 2001.
Office Action received for U.S. Pat. No. 6,355,050 dated Oct. 13, 1999.
Office Action received for U.S. Pat. No. 6,355,050 dated Oct. 23, 2000.
Office Action received for U.S. Pat. No. 6,517,553 dated Jun. 17, 2002.
Office Action received for U.S. Pat. No. 6,517,553 dated Oct. 23, 2001.
Office Action received for U.S. Pat. No. 6,558,399 dated Jul. 11, 2002.
Office Action received for U.S. Pat. No. 7,029,480 dated Mar. 17, 2005.
U.S. Appl. No. 16/052,263, Jun. 2, 2020, Office Action.
U.S. Appl. No. 15/090,150, Dec. 31, 2019, Office Action.
Related Publications (1)
Number Date Country
20150025551 A1 Jan 2015 US
Continuations (1)
Number Date Country
Parent 13455053 Apr 2012 US
Child 14511730 US
Continuation in Parts (1)
Number Date Country
Parent 13443659 Apr 2012 US
Child 13455053 US